# API 并排问答 — 同一问题 × 8 检索算法

## sf-001 — 0-dimensional biomaterials lack inductive properties.

金标: 31715818

中间 Agent 排名: itrg_refresh(10.0) > deepread(9.0) > search_o1(9.0) > dense_rag(7.0) > itrg_refine(7.0) > dense_rag_rerank(7.0) > raptor(7.0) > qdcvr(6.0)

### qdcvr

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=2
- 回答(insufficient): Neither retrieved excerpt addresses biomaterials or their inductive properties: the first concerns mortality trends amenable to medical care in eastern Europe, and the second concerns meiotic recombination hotspots in the mouse MHC Ebeta gene. With no evidence on 0-dimensional biomaterials or inductive capacity, the claim cannot be supported or refuted from the supplied corpus.

### dense_rag

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=7
- 回答(insufficient): The retrieved excerpts concern nitric oxide synthase/ peroxynitrite cytotoxicity, mGluR6 knockout visual transmission, and small-molecule enhancement of induced pluripotent stem cell reprogramming. None addresses biomaterial dimensionality (0-dimensional vs. other) or the inductive properties of biomaterials, so the claim cannot be evaluated from this evidence.

### dense_rag_rerank

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=8
- 回答(insufficient): None of the three retrieved excerpts address 0-dimensional biomaterials or their inductive properties. The evidence concerns embryonic BMP/ADMP morphogenetic self-regulation, small-molecule enhancement of iPSC reprogramming, and Myc-driven protein synthesis in cancer, none of which bear on the dimensionality of biomaterials. The claim therefore cannot be assessed from the provided corpus.

### raptor

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=7
- 回答(insufficient): The claim concerns the inductive properties of 0-dimensional biomaterials, but none of the three retrieved excerpts address biomaterials, dimensionality, or tissue-inductive behavior. The passages cover peroxynitrite-mediated cytotoxicity in L-Arg-depleted cells, loss of ON visual responses in mGluR6 knockout mice, and small-molecule enhancement of iPSC reprogramming, none of which bear on the claim. No evidence in the corpus is relevant, so the claim can be neither supported nor refuted.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): None of the three retrieved excerpts addresses dimensionality of biomaterials or inductive properties. They concern nanotechnology for stem cell tracking/differentiation, prostaglandin E2 regulation of bone homeostasis, and outer membrane biogenesis in E. coli, so the claim cannot be evaluated from this evidence.

### itrg_refine

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.333 judge=7
- 回答(insufficient): The retrieved excerpts concern nitric oxide synthase/ peroxynitrite cytotoxicity, mGluR6 knockout visual transmission, and small-molecule enhancement of induced pluripotent stem cell reprogramming. None addresses biomaterial dimensionality (0-dimensional vs. other) or the inductive properties of biomaterials, so the claim cannot be evaluated from this evidence.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): Neither retrieved excerpt addresses 0-dimensional biomaterials or their inductive properties. Source 31715818 reviews nanotechnology platforms for stem cell labeling, delivery, and scaffold-based differentiation, and source 21676556 concerns midbody accumulation in stem cells; both relate to stem cell manipulation but neither defines dimensionality of biomaterials nor evaluates induction (e.g., osteogenic/chondrogenic differentiation) capability. The claim is therefore neither supported nor refuted by the provided evidence.

### deepread

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.500 judge=9
- 回答(insufficient): None of the three retrieved excerpts address 0-dimensional biomaterials or their inductive properties. The passages concern optogenetic trafficking strategies [8386609], replacement of OCT4/SOX2 in human cell reprogramming [16287725], and nanotechnology applications for stem cell tracking, differentiation, and transplantation [31715818]. Although [31715818] mentions engineered nanometer-scale scaffolds, it does not classify dimensionality nor assess inductive capability, so the claim cannot be evaluated from this evidence.

## sf-002 — 4-PBA treatment decreases endoplasmic reticulum stress in response to general endoplasmic reticulum stress markers.

金标: 32587939

中间 Agent 排名: qdcvr(10.0) > dense_rag_rerank(9.0) > deepread(9.0) > itrg_refine(8.0) > itrg_refresh(8.0) > raptor(8.0) > dense_rag(7.0) > search_o1(7.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=7
- 回答(insufficient): The two provided excerpts discuss ER stress biology (WFS1/AC8 complex formation and VAP-dependent endosome-ER contacts) but neither mentions 4-PBA (4-phenylbutyrate) treatment nor reports effects on general ER stress markers. No data on 4-PBA administration or marker changes (e.g., CHOP, BiP/GRP78, ATF4, XBP1) is present, so the claim cannot be evaluated from this evidence.

### dense_rag

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(insufficient): None of the three retrieved excerpts mention 4-PBA (sodium phenylbutyrate) or any chaperone/chemical treatment, and none measure general ER stress markers under such treatment; they concern VAP-dependent endosome-ER PI4P regulation, WFS1/AC8 ER stress signaling in beta cells, and G-quadruplex compounds in HR-deficient cells. The claim about 4-PBA decreasing ER stress is therefore not evaluable from the provided evidence.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=7
- 回答(insufficient): None of the retrieved excerpts mention 4-PBA (4-phenylbutyric acid) or any treatment intervention; they describe WFS1/AC8 regulation of insulin secretion under ER stress and VAP-dependent endosome-ER contacts. The excerpts also report no general ER stress marker measurements (e.g., BiP/GRP78, CHOP, ATF4, XBP1) with or without treatment. Therefore the claim cannot be evaluated from the provided evidence.

### raptor

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(insufficient): None of the three retrieved excerpts mention 4-PBA (4-phenylbutyric acid) or any treatment with it, nor do they report measurements of general ER stress markers before and after such treatment. The excerpts concern ER-endosome contact/PI4P regulation (600437), WFS1-AC8 interactions under ER stress (32587939), and G-quadruplex compounds in BRCA-deficient cells (16472469), none of which provide evidence for or against the claim.

### itrg_refresh

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=8
- 回答(insufficient): None of the three retrieved excerpts mention 4-PBA (4-phenylbutyric acid) or any treatment with it, nor do they report measurements of general ER stress markers before and after such treatment. The excerpts concern ER-endosome contact/PI4P regulation (600437), WFS1-AC8 interactions under ER stress (32587939), and G-quadruplex compounds in BRCA-deficient cells (16472469), none of which provide evidence for or against the claim.

### itrg_refine

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(insufficient): None of the three retrieved excerpts mention 4-PBA (4-phenylbutyric acid) or any treatment with it, nor do they report measurements of general ER stress markers before and after such treatment. The excerpts concern ER-endosome contact/PI4P regulation (600437), WFS1-AC8 interactions under ER stress (32587939), and G-quadruplex compounds in BRCA-deficient cells (16472469), none of which provide evidence for or against the claim.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): Neither retrieved excerpt evaluates 4-PBA (4-phenylbutyric acid) or reports any general ER stress marker measurements following its treatment. Source [32587939] concerns WFS1/AC8 complex formation and insulin secretion during ER stress, and source [4961038] concerns PI3K/MEK inhibitors in K-Ras and PIK3CA mutant lung cancers; neither mentions 4-PBA or ER stress marker quantification. Therefore the claim cannot be assessed from the provided evidence.

### deepread

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(insufficient): None of the provided excerpts mention 4-PBA (4-phenylbutyrate) or any treatment reducing endoplasmic reticulum stress markers. Sources [32587939] and the others discuss ER stress mechanisms (WFS1/AC8 in β-cells) and unrelated topics (G-quadruplex replication, bacterial two-component signaling), but contain no data on 4-PBA treatment or its effect on general ER stress markers. The claim therefore cannot be evaluated from this evidence.

## sf-003 — Pyridostatin stabilizes the G - quadruplex in the telomeric region.

金标: 16472469

中间 Agent 排名: itrg_refresh(10.0) > raptor(9.0) > dense_rag_rerank(9.0) > deepread(9.0) > search_o1(9.0) > qdcvr(8.0) > dense_rag(8.0) > itrg_refine(7.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Source [16472469] explicitly identifies pyridostatin (PDS) as a "G4-stabilizing compound" and describes G-quadruplex (G4)-forming genomic sequences as including telomeres, with G-rich telomeric repeats. Treatment with PDS increased telomere fragility, indicating that it stabilizes G4 structures in the telomeric region. The claim is therefore directly supported by this evidence.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Source 16472469 explicitly identifies pyridostatin (PDS) as a "G4-stabilizing compound" and notes that G-quadruplex-forming genomic sequences include telomeres, with PDS treatment increasing telomere fragility in BRCA2-deficient cells. This directly supports that pyridostatin stabilizes G-quadruplexes in the telomeric region. Source 58006489 (PGE2/bone homeostasis) is irrelevant to the claim.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence identifies pyridostatin (PDS) as a G4-stabilizing compound and states that G4-forming genomic sequences include telomeres; PDS treatment increases telomere fragility in BRCA2-deficient cells, which the authors attribute to G4 formation driving telomere instability. Thus PDS is described as stabilizing G-quadruplexes in the context of telomeric G-rich repeats, though the excerpt asserts the telomere-level effect indirectly via fragility rather than a direct biophysical measurement of stabilization at telomeres.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(supported): Pyridostatin (PDS) is explicitly described as a G4-stabilizing compound in the retrieved evidence, and telomeres are listed among G4-forming genomic sequences. This is corroborated by the telomeric phenotype: PDS increased telomere fragility in BRCA2-deficient cells, consistent with stabilized telomeric G-quadruplexes driving telomere instability. The claim is therefore directly supported by the corpus excerpts, which characterize PDS as a G4-stabilizer acting on telomeric G4 structures.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence identifies pyridostatin (PDS) as a G4-stabilizing compound and states that G-quadruplex-forming genomic sequences include telomeres, so PDS acts on telomeric G4 structures. Treatment with PDS increased telomere fragility in BRCA2-deficient cells, which the authors attribute to G4 formation driving telomere instability. The claim that pyridostatin stabilizes the G-quadruplex in the telomeric region is therefore consistent with the cited excerpts.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Source 16472469 explicitly identifies pyridostatin (PDS) as a "G4-stabilizing compound" and states that G-quadruplex (G4)-forming genomic sequences include telomeres. It further reports that PDS treatment increases telomere fragility in BRCA2-deficient cells, consistent with PDS stabilizing telomeric G-quadruplexes and thereby driving telomere instability. The remaining sources concern bone homeostasis and IL-2 autoimmunity and are irrelevant to the claim.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence explicitly identifies pyridostatin (PDS) as a G4-stabilizing compound and describes telomeres as G-quadruplex-forming genomic sequences. Treatment with PDS increases telomere fragility, which the authors attribute to G4 formation driving telomere instability, confirming that PDS stabilizes telomeric G-quadruplexes.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence explicitly identifies pyridostatin (PDS) as a G4-stabilizing compound and notes that G-quadruplex-forming genomic sequences include telomeres, with PDS treatment increasing telomere fragility. This directly supports the claim that pyridostatin stabilizes the G-quadruplex in the telomeric region. The telomere-specific effect is inferred from PDS increasing telomere fragility and reducing replication efficiency of G-rich telomeric repeats.

## sf-004 — R2D2 stops miRNA production by increasing the selectivity of Dcr2 for long dsRNA.

金标: 5702790

中间 Agent 排名: raptor(9.0) > qdcvr(9.0) > search_o1(8.0) > itrg_refine(8.0) > dense_rag_rerank(8.0) > dense_rag(7.0) > itrg_refresh(7.0) > deepread(2.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Source [5702790] reports that Dicer-2 can efficiently cleave pre-miRNA, but that its partner protein R2D2 inhibits pre-miRNA cleavage, which is consistent with R2D2 blocking miRNA production. The same study frames R2D2 (with inorganic phosphate) as restricting Dicer-2's substrate specificity toward its biological substrate, long dsRNA. Source [13923140] is unrelated (IL-2/autoimmunity) and provides no relevant evidence.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence supports that R2D2 blocks miRNA production: purified Dicer-2 efficiently cleaves pre-miRNA, but R2D2 inhibits pre-miRNA cleavage, and the work is framed as phosphate and R2D2 restricting Dicer-2's substrate specificity (shifting it away from pre-miRNA toward its long-dsRNA/siRNA role). The abstract does not quantify enhanced long-dsRNA selectivity directly, but the described restriction of Dicer-2 specificity by R2D2 is consistent with the claim's mechanism.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence states that the Dicer-2 partner protein R2D2 inhibits pre-miRNA cleavage by Dicer-2 (together with inorganic phosphate), consistent with the paper's framing that R2D2 restricts Dicer-2's substrate specificity. Because Dicer-2 retains efficient long dsRNA processing, this inhibition of pre-miRNA cleavage amounts to shifting Dicer-2 selectivity toward long dsRNA, thereby suppressing miRNA production. The claim matches the excerpt, though the direct selectivity measurement itself is only implied by the reported inhibition of pre-miRNA cleavage.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence directly shows that the Dicer-2 partner protein R2D2 inhibits purified Dicer-2 from cleaving pre-miRNA, and the paper's title frames R2D2 (with inorganic phosphate) as restricting Dicer-2's substrate specificity, biasing it toward its biological substrate long dsRNA. Thus R2D2 suppresses miRNA production by making Dicer-2 selective for long dsRNA over pre-miRNA. Note the excerpts demonstrate this inhibition in vitro and do not detail the molecular mechanism by which R2D2 alters selectivity.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(supported): The evidence supports that R2D2 blocks miRNA production: purified Dicer-2 efficiently cleaves pre-miRNA, but R2D2 inhibits pre-miRNA cleavage, and the work is framed as phosphate and R2D2 restricting Dicer-2's substrate specificity (shifting it away from pre-miRNA toward its long-dsRNA/siRNA role). The abstract does not quantify enhanced long-dsRNA selectivity directly, but the described restriction of Dicer-2 specificity by R2D2 is consistent with the claim's mechanism.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(supported): The evidence shows that R2D2, together with inorganic phosphate, inhibits Dicer-2 cleavage of pre-miRNA while Dicer-2 productively processes long dsRNA, and the study frames this as restricting Dicer-2's substrate specificity — consistent with R2D2 blocking miRNA production by making Dicer-2 selective for long dsRNA. The abstract supports both the inhibitory effect on pre-miRNA cleavage and the specificity-restriction mechanism, though the selectivity increase is inferred from the specificity-restriction framing rather than stated as a direct measurement.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows that the Dicer-2 partner protein R2D2 inhibits cleavage of pre-miRNA by purified Dicer-2, and the paper frames this as phosphate and R2D2 restricting Dicer-2's substrate specificity toward its biological substrate, long dsRNA. Since Dicer-1 produces miRNAs from pre-miRNA, blocking Dicer-2's pre-miRNA cleavage would prevent it from generating miRNAs, consistent with R2D2 biasing Dcr2 activity away from pre-miRNA toward long dsRNA. The excerpts do not quantify a change in long-dsRNA affinity directly, but the reported inhibition of pre-miRNA processing and narrowed substrate specificity support the claim.

### deepread

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=5
- 回答(insufficient): No evidence was retrieved from the corpus, so the claim that R2D2 increases Dcr2's selectivity for long dsRNA to stop miRNA production cannot be assessed. Verification would require corpus passages describing R2D2's role in Dcr2 substrate discrimination between siRNA-precursor-length and pre-miRNA-length dsRNA.

## sf-005 — RA activation of DIF2 and NB4 cells induces hallmarks of transcriptionally active promoters.

金标: 13639330

中间 Agent 排名: itrg_refine(9.0) > deepread(8.8) > raptor(8.5) > search_o1(8.5) > dense_rag(8.5) > dense_rag_rerank(8.5) > itrg_refresh(8.5) > qdcvr(6.5)

### qdcvr

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=1
- 回答(insufficient): The provided excerpts are unrelated to the claim: one concerns Ca2+-permeable AMPA receptor signaling via Akt in glioblastoma, and the other concerns NuA4/Esa1 acetyltransferase recruitment to coding regions in yeast. Neither excerpt mentions retinoic acid (RA), the cell lines DIF2 or NB4, nor transcriptional activation specifically in those cells. No evidence bearing on the claim is present.

### dense_rag

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=8
- 回答(insufficient): The retrieved evidence concerns RA-induced IEX-1 expression in NB4 and KG1 cells, including two functional RA-response elements in the IEX-1 promoter, but never mentions DIF2 cells nor any assays of transcriptionally active promoter hallmarks (e.g., H3K4me3, H3K27ac, RNA Pol II occupancy). No statement in the excerpt can therefore confirm or contradict the claim as phrased.

### dense_rag_rerank

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=7
- 回答(insufficient): The retrieved evidence concerns RA-induced IEX-1 expression in NB4 and KG1 cells, including two functional RA-response elements in the IEX-1 promoter, but never mentions DIF2 cells nor any assays of transcriptionally active promoter hallmarks (e.g., H3K4me3, H3K27ac, RNA Pol II occupancy). No statement in the excerpt can therefore confirm or contradict the claim as phrased.

### raptor

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=2
- 回答(insufficient): The evidence shows that RA rapidly induces the immediate early gene IEX-1 in the APL lines NB4 (PML-RARα) and KG1 (PLZF-RARα), via two functional RA-response elements in the IEX-1 promoter, confirming direct transcriptional induction. However, it concerns NB4 and KG1, not DIF2, and never assesses hallmarks of transcriptionally active promoters (e.g., activating histone marks or RNA Pol II occupancy). No evidence about DIF2 or promoter-activity hallmarks is present, so the claim cannot be verified.

### itrg_refresh

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=6
- 回答(insufficient): The retrieved evidence concerns RA-induced IEX-1 expression in NB4 and KG1 cells, including two functional RA-response elements in the IEX-1 promoter, but never mentions DIF2 cells nor any assays of transcriptionally active promoter hallmarks (e.g., H3K4me3, H3K27ac, RNA Pol II occupancy). No statement in the excerpt can therefore confirm or contradict the claim as phrased.

### itrg_refine

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=3
- 回答(insufficient): The corpus only addresses RA-induced IEX-1 expression in NB4 and KG1 cells, plus an unrelated glioblastoma AMPA-receptor/Akt pathway. Neither excerpt mentions DIF2 cells, and neither reports assays of transcriptionally active promoter hallmarks (e.g., H3K4me3, H3K27ac, promoter-proximal Pol II). The NB4 portion of the claim is at best tangential, and the DIF2/promoter-hallmark components are wholly unsupported.

### search_o1

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=3
- 回答(insufficient): The corpus only supports that RA rapidly induces the IEX-1 gene in NB4 cells (and KG1 cells), with two functional RA-response elements mapped in the IEX-1 promoter; it says nothing about DIF2, and neither excerpt reports chromatin marks or other hallmarks of transcriptionally active promoters (e.g., H3K4me3, H3K27ac, Pol II occupancy) at these loci. Source [29788648] concerns yeast NuA4/Esa1 and is unrelated to RA or NB4. Therefore the claim's specific gene set (DIF2 and NB4 cells) and its promoter-hallmark assertion are not verifiable from the provided evidence.

### deepread

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=6
- 回答(insufficient): The evidence supports RA-induced transcriptional activation in NB4 cells: IEX-1 is rapidly induced by all-trans- or cis-RA within 30-60 min, and two functional RA-response elements in the IEX-1 promoter were confirmed by gel shift and luciferase reporter assays. However, no data on DIF2 cells is provided (the second cell line studied is KG1, not DIF2), and the excerpts report promoter-reporter activity and transcript induction rather than canonical hallmarks of transcriptionally active promoters (e.g. H3K4me3/H3K27ac, Pol II occupancy, chromatin accessibility). The claim therefore cannot be verified as stated.

## sf-006 — RAD52 is involved in break-induced DNA replication (BIR).

金标: 14332945, 4319844, 4899981

中间 Agent 排名: dense_rag(10.0) > dense_rag_rerank(10.0) > itrg_refresh(10.0) > raptor(9.0) > search_o1(8.0) > qdcvr(8.0) > deepread(8.0) > itrg_refine(7.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Both evidence sources directly link RAD52 to break-induced replication (BIR). Source 14332945 shows mammalian RAD52 localizes to DNA replication stress foci and is required to restart collapsed forks via BIR repair, while source 4899981 demonstrates that mitotic DNA synthesis at telomeres and common fragile sites requires a RAD52-dependent form of break-induced replication. Together they establish RAD52 as a factor involved in BIR.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The retrieved evidence directly supports the claim: the source is titled "Mammalian RAD52 Functions in Break-Induced Replication Repair of Collapsed DNA Replication Forks," and the abstract states that a screen for BIR-related genes identified RAD52 among the top hits. It further reports that Rad52 localizes to replication-stress foci and that its depletion or knockout compromises restart of collapsed forks, leading the authors to propose that mammalian RAD52 facilitates repair of collapsed replication forks in cancer cells.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence directly supports the claim: the source is titled "Mammalian RAD52 Functions in Break-Induced Replication Repair of Collapsed DNA Replication Forks" and states that cells experiencing oncogene-induced replication stress depend on BIR for damaged forks. RAD52 was a top hit in a screen for genes required for G1-to-S progression, its protein localized to DNA replication stress foci, and Rad52 depletion or CRISPR knockout compromised restart of collapsed forks, leading the authors to propose that mammalian RAD52 facilitates repair of collapsed replication forks.

### raptor

- 指标: hit@1=1.000 R@5=0.667 nDCG@10=0.765 judge=9
- 回答(supported): The evidence directly supports the claim: a targeted siRNA screen and CRISPR/Cas9 knockout studies identify mammalian RAD52 as required for break-induced replication (BIR) repair, with Rad52 localizing to DNA replication stress foci and its loss compromising restart of collapsed forks. A separate study shows telomeric mitotic DNA synthesis (MiDAS), a RAD52-dependent process resembling BIR, requires RAD52. Both sources conclude that RAD52-dependent BIR helps cells, particularly cancer cells under replication stress, tolerate collapsed forks and telomeres.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence directly supports the claim: the source is titled "Mammalian RAD52 Functions in Break-Induced Replication Repair of Collapsed DNA Replication Forks" and states that cells experiencing oncogene-induced replication stress depend on BIR for damaged forks. RAD52 was a top hit in a screen for genes required for G1-to-S progression, its protein localized to DNA replication stress foci, and Rad52 depletion or CRISPR knockout compromised restart of collapsed forks, leading the authors to propose that mammalian RAD52 facilitates repair of collapsed replication forks.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): All three evidence sources link RAD52 to break-induced replication (BIR). Source [4899981] states that at common fragile sites and telomeres cells switch to a RAD52-dependent form of break-induced replication (MiDAS), and source [4319844] describes telomeric MiDAS as RAD52-dependent, RAD51-independent DNA synthesis potentially mediated by BIR. Source [14332945] adds that mammalian RAD52 localizes to replication-stress foci and promotes restart of collapsed forks, the repair process the authors place within BIR. The claim that RAD52 is involved in BIR is therefore supported.

### search_o1

- 指标: hit@1=1.000 R@5=0.667 nDCG@10=0.765 judge=9
- 回答(supported): Both sources directly link RAD52 to break-induced replication (BIR). Source 14332945 identifies mammalian RAD52 as required for restart of collapsed replication forks via BIR repair, localizing Rad52 to DNA replication stress foci and showing that Rad52 depletion or knockout compromises fork restart. Source 4899981 independently reports that RAD52-dependent BIR is required for mitotic DNA synthesis (MiDAS) at telomeres and common fragile sites, indicating RAD52 is a conserved factor in BIR.

### deepread

- 指标: hit@1=1.000 R@5=0.667 nDCG@10=0.765 judge=9
- 回答(supported): Both sources explicitly link RAD52 to break-induced replication (BIR). Source 14332945 identifies RAD52 as a top hit in a BIR-related screen and shows Rad52 depletion/knockout compromises restart of collapsed forks during replication stress, proposing mammalian RAD52 facilitates repair of collapsed forks. Source 4899981 states that mitotic DNA synthesis at telomeres and common fragile sites requires RAD52 and is a RAD52-dependent form of break-induced replication.

## sf-007 — RANK-RANKL pathway signalling has no known association with development of Aire-expressing medullary thymic epithelial cells.

金标: 2734421, 301838, 3952288

中间 Agent 排名: deepread(9.0) > itrg_refresh(9.0) > raptor(8.0) > dense_rag_rerank(8.0) > itrg_refine(8.0) > qdcvr(8.0) > dense_rag(7.0) > search_o1(7.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(refuted): The claim is contradicted by both retrieved sources, which directly establish that RANK-RANKL signalling drives the development of Aire-expressing mTECs. Source 3952288 shows RANKL signals from CD4+3− inducer cells promote maturation of RANK-expressing CD80−Aire− mTEC progenitors into CD80+Aire+ mTECs, with RANK-deficient thymic stroma inducing autoimmunity. Source 301838 independently reports that emergence of the first Aire+ mTEC cohorts is jointly directed by Rankl+ lymphoid tissue inducer cells and Vγ5+ DETC progenitors, describing a Rank-mediated link to Aire+ mTEC maturation.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(refuted): The evidence directly contradicts the claim: RANKL signals from CD4+3− inducer cells were shown to promote maturation of RANK-expressing CD80−Aire− mTEC progenitors into CD80+Aire+ mTECs, and RANK-deficient thymic stroma transplants induced autoimmunity. A second study found Aire+ mTEC emergence is jointly directed by Rankl+ lymphoid tissue inducer cells and Vγ5+ DETC progenitors via a Rank-mediated reciprocal link. Thus RANK-RANKL signalling is well documented as associated with, and required for, Aire-expressing mTEC development.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The claim is directly contradicted by the retrieved evidence. Source [3952288] shows RANKL signals from CD4+3− inducer cells promote maturation of RANK-expressing mTEC progenitors into CD80+Aire+ mTECs, and RANK-deficient thymic stroma induces autoimmunity. Sources [301838] and [2734421] independently confirm that Rank/RANKL signaling (with CD40 cooperation postnatally) is essential for Aire+ mTEC development, establishing a well-documented association rather than an absent one.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(refuted): The claim is directly contradicted: RANKL signals from CD4+3− inducer cells promote maturation of RANK-expressing CD80−Aire− mTEC progenitors into CD80+Aire+ mTECs, and RANK signaling is required for mTEC development. A Rank-mediated reciprocal DETC–mTEC link, together with Rankl+ lymphoid tissue inducer cells, also directs emergence of the first Aire+ mTECs. Thus a well-established RANK–RANKL association with Aire-expressing mTEC development exists, so the claim of no known association is false.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(refuted): The claim is contradicted by the corpus: RANKL signals from CD4+3− inducer cells promote maturation of RANK-expressing CD80−Aire− mTEC progenitors into CD80+Aire+ mTECs, establishing a direct RANK-RANKL role in Aire+ mTEC generation. A second study confirms RANK signaling is essential for mTEC development (required during embryogenesis, cooperating with CD40 postnatally) to establish self-tolerance.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The claim is directly contradicted by the retrieved evidence. Source [3952288] shows RANKL signals from CD4+3− inducer cells promote maturation of RANK-expressing mTEC progenitors into CD80+Aire+ mTECs, and RANK-deficient thymic stroma induces autoimmunity. Sources [301838] and [2734421] independently confirm that Rank/RANKL signaling (with CD40 cooperation postnatally) is essential for Aire+ mTEC development, establishing a well-documented association rather than an absent one.

### search_o1

- 指标: hit@1=1.000 R@5=0.333 nDCG@10=0.469 judge=7
- 回答(refuted): The evidence directly contradicts the claim, showing that CD4+3−RANKL+ inducer cells signal through RANK on CD80−Aire− mTEC progenitors to promote their maturation into CD80+Aire+ mTECs. RANK-deficient thymic stroma transplanted into immunodeficient hosts induced autoimmunity, and the appearance of these inducer cells is temporally linked to Aire+ mTEC emergence. Thus RANK-RANKL signalling is causally associated with the development of Aire-expressing mTECs.

### deepread

- 指标: hit@1=1.000 R@5=0.667 nDCG@10=0.765 judge=9
- 回答(refuted): Both retrieved sources directly link RANK-RANKL signalling to Aire-expressing mTEC development, contradicting the claim. Source [2734421] shows RANK signalling is essential for mTEC development (embryonic) and cooperates with CD40 postnatally via TRAF6/NIK/IKKbeta. Source [301838] shows emergence of the first Aire(+) mTEC cohorts is jointly directed by Rankl(+) lymphoid tissue inducer cells, establishing a Rank-mediated link to Aire(+) mTEC maturation.

## sf-008 — RANK-RANKL pathway signalling is linked to development of Aire-expressing medullary thymic epithelial cells.

金标: 2734421, 301838, 3952288

中间 Agent 排名: raptor(10.0) > itrg_refine(10.0) > dense_rag(9.0) > qdcvr(9.0) > dense_rag_rerank(9.0) > itrg_refresh(9.0) > search_o1(8.0) > deepread(1.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(supported): Both retrieved sources directly link RANK/RANKL signalling to the development of Aire-expressing medullary thymic epithelial cells. Source 3952288 shows RANKL signals from CD4+3− inducer cells promote maturation of RANK-expressing CD80−Aire− mTEC progenitors into CD80+Aire+ mTECs, and source 301838 shows Rankl+ lymphoid tissue inducer cells jointly direct the emergence of Aire+ mTECs in a Rank-mediated reciprocal link. The claim is therefore corroborated by the evidence.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(supported): The evidence directly supports the claim: RANKL signals from CD4+3− inducer cells promote maturation of RANK-expressing CD80−Aire− mTEC progenitors into CD80+Aire+ mTECs, and transplantation of RANK-deficient thymic stroma induces autoimmunity [3952288]. A second study independently reports that emergence of the first Aire+ mTEC cohorts is jointly directed by Rankl+ lymphoid tissue inducer cells, establishing a Rank-mediated link between these cells and Aire+ mTEC maturation [301838]. Together the sources confirm that RANK–RANKL signalling is linked to development of Aire-expressing mTECs.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=7
- 回答(supported): The evidence directly shows that RANKL signals from CD4+3− inducer cells promote maturation of RANK-expressing CD80−Aire− mTEC progenitors into CD80+Aire+ medullary thymic epithelial cells, and that RANK-deficient thymic stroma induces autoimmunity. This establishes a functional link between RANK-RANKL signalling and the development of Aire-expressing mTECs. The claim is therefore supported.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=7
- 回答(supported): The evidence directly links RANK–RANKL signalling to the development of Aire-expressing medullary thymic epithelial cells (mTECs). RANK signalling was essential during embryogenesis, and RANKL signals from CD4+3− inducer cells promote maturation of RANK-expressing CD80−Aire− mTEC progenitors into CD80+Aire+ mTECs, with ligation of RANK on fetal thymic stroma inducing mTEC development via TRAF6, NIK and IKKβ. RANK-deficient thymic stroma transplanted into immunodeficient hosts induced autoimmunity, further tying the pathway to Aire+ mTEC generation and self-tolerance.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=7
- 回答(supported): The evidence directly shows that RANKL signals from CD4+3− inducer cells promote maturation of RANK-expressing CD80−Aire− mTEC progenitors into CD80+Aire+ medullary thymic epithelial cells, and that RANK-deficient thymic stroma induces autoimmunity. This establishes a functional link between RANK-RANKL signalling and the development of Aire-expressing mTECs. The claim is therefore supported.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=7
- 回答(supported): All three sources link RANK/RANKL signalling to the development of Aire-expressing medullary thymic epithelial cells (mTECs). RANKL from CD4+3- inducer cells promotes maturation of RANK-expressing CD80-Aire- mTEC progenitors into CD80+Aire+ mTECs, and RANKL+ lymphoid tissue inducer cells together with Vγ5+ DETC progenitors direct emergence of the first Aire+ mTEC cohorts. RANK and CD40 signals cooperatively regulate mTEC development, with RANK signalling being essential during embryogenesis.

### search_o1

- 指标: hit@1=1.000 R@5=0.333 nDCG@10=0.469 judge=6
- 回答(supported): The evidence directly supports the claim: RANKL signals from CD4+3− inducer cells act on RANK-expressing CD80−Aire− mTEC progenitors, promoting their maturation into CD80+Aire+ medullary thymic epithelial cells. The appearance of these inducer cells in fetal thymus is also temporally linked to the appearance of Aire+ mTECs, and RANK-deficient thymic stroma transplantation induces autoimmunity, implicating the RANK-RANKL axis in Aire+ mTEC generation.

### deepread

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=2
- 回答(insufficient): No evidence excerpts were retrieved from the corpus, so the claim that RANK-RANKL pathway signalling is linked to the development of Aire-expressing medullary thymic epithelial cells cannot be assessed. The provided evidence set is empty, leaving the claim neither supported nor refuted by the available material.

## sf-009 — RTEL1 interacts with TRF2 through a C4C4 motif

金标: 4926049

中间 Agent 排名: dense_rag_rerank(10.0) > itrg_refresh(10.0) > dense_rag(10.0) > search_o1(10.0) > raptor(10.0) > deepread(10.0) > itrg_refine(8.0) > qdcvr(8.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Source [4926049] directly establishes that the shelterin protein TRF2 recruits RTEL1 to telomeres in S phase, and that this TRF2-RTEL1 interaction is mediated by a metal-coordinating C4C4 motif in RTEL1. The same study identifies the HHS mutation RTEL1(R1264H) as compromising this motif and TRF2(I124D) as eliminating RTEL1 binding, confirming the C4C4 motif's role in the interaction. Source [13964633] is irrelevant (versican 3'UTR/miRNA) and provides no bearing on the claim.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence states that the TRF2-RTEL1 interaction is mediated by a metal-coordinating C4C4 motif in RTEL1, with the HHS mutation RTEL1(R1264H) compromising this interaction, and that a TRF2(I124D) substitution in the TRFH domain eliminates RTEL1 binding. This directly supports the claim that RTEL1 interacts with TRF2 through a C4C4 motif in RTEL1.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The claim is supported: the corpus states that the TRF2-RTEL1 interaction is mediated by a metal-coordinating C4C4 motif in RTEL1, which is compromised by the HHS mutation RTEL1(R1264H). TRF2 recruits RTEL1 to telomeres in S phase via this interaction, and the TRF2(I124D) mutation eliminating RTEL1 binding phenocopies the RTEL1(R1264H) mutation. Thus RTEL1 engages TRF2 through the C4C4 motif.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence states that the TRF2-RTEL1 interaction is mediated by a metal-coordinating C4C4 motif in RTEL1, which is required for TRF2 to recruit RTEL1 to telomeres in S phase. Disruption of this interaction by the RTEL1(R1264H) mutation or the TRF2(I124D) substitution abolishes RTEL1 binding, confirming the C4C4 motif's role. The claim is directly supported by the cited excerpts.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The claim is supported: the corpus states that the TRF2-RTEL1 interaction is mediated by a metal-coordinating C4C4 motif in RTEL1, which is compromised by the HHS mutation RTEL1(R1264H). TRF2 recruits RTEL1 to telomeres in S phase via this interaction, and the TRF2(I124D) mutation eliminating RTEL1 binding phenocopies the RTEL1(R1264H) mutation. Thus RTEL1 engages TRF2 through the C4C4 motif.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Source [4926049] directly establishes that the shelterin protein TRF2 recruits RTEL1 to telomeres in S phase and that the TRF2-RTEL1 interaction is mediated by a metal-coordinating C4C4 motif in RTEL1. The same study shows this interaction is disrupted by the disease mutation RTEL1(R1264H) and abolished by TRF2(I124D), confirming the C4C4 motif as the binding determinant. The other two sources concern 5S rRNA assembly and IEX-1 induction and provide no relevant evidence.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence states that the TRF2-RTEL1 interaction is mediated by a metal-coordinating C4C4 motif in RTEL1, and that the HHS mutation RTEL1(R1264H) compromises this interaction. A TRF2(I124D) mutation in the TRFH domain eliminates RTEL1 binding and phenocopies RTEL1(R1264H), confirming the C4C4 motif-dependent TRF2-RTEL1 interaction. Thus the claim is directly supported.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence states that the shelterin protein TRF2 recruits RTEL1 to telomeres in S phase, and that this TRF2-RTEL1 interaction is mediated by a metal-coordinating C4C4 motif in RTEL1. The interaction is disrupted by the RTEL1(R1264H) HHS mutation and by a TRF2(I124D) substitution that eliminates RTEL1 binding, confirming the C4C4 motif as the mediating element.

## sf-010 — RUNX is not expressed in skin tissue.

金标: 2547636

中间 Agent 排名: deepread(10.0) > dense_rag_rerank(9.0) > dense_rag(8.0) > itrg_refine(8.0) > itrg_refresh(8.0) > raptor(8.0) > search_o1(8.0) > qdcvr(7.0)

### qdcvr

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=7
- 回答(insufficient): Neither retrieved excerpt addresses RUNX or its expression in skin tissue. Source 28230867 concerns insect telomerase activity and 12486491 concerns Rpl38-mediated Hox mRNA translation in mice; no RUNX expression data, skin-tissue assay, or negative expression result is reported. The claim therefore cannot be evaluated from the provided evidence.

### dense_rag

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=7
- 回答(insufficient): The retrieved evidence does not address RUNX expression at all: source [17081238] concerns mGluR6 in retinal ON bipolar cells, and source [36838958] concerns Sestrin2/ROS regulation of Ucp1 in brown adipose tissue. Neither excerpt reports any measurement of RUNX in skin or any other tissue, so the claim can be neither supported nor refuted from this evidence.

### dense_rag_rerank

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(insufficient): The provided evidence does not address RUNX expression in skin tissue. Source 1982286 concerns RUNX1's tumor-suppressor role in T cell acute lymphoblastic leukemia, and source 2547636 describes circadian regulation of human epidermal stem cells without mentioning RUNX. Neither excerpt reports on RUNX expression in skin, so the claim cannot be verified or refuted from this corpus.

### raptor

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=9
- 回答(insufficient): None of the three retrieved excerpts address RUNX expression or skin tissue: they concern mGluR6 in retinal ON bipolar cells, Sestrin2/Ucp1 regulation in brown adipose tissue, and telomerase activity in insect somatic and germline tissues. No evidence in the corpus bears on whether RUNX is expressed in skin, so the claim can be neither supported nor refuted from these sources.

### itrg_refresh

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=3
- 回答(insufficient): The retrieved evidence concerns Sestrin2-mediated regulation of uncoupling protein 1 (Ucp1) expression and reactive oxygen species in brown adipose tissue; it contains no information about RUNX expression or about skin tissue. Therefore the claim that RUNX is not expressed in skin tissue can be neither supported nor refuted by these excerpts.

### itrg_refine

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=9
- 回答(insufficient): None of the retrieved evidence addresses RUNX expression or skin tissue. The excerpts concern mGluR6 in retinal ON bipolar cells, Sestrin2 regulation of Ucp1 in brown adipose tissue, and telomerase activity in insects, none of which report on RUNX transcripts or protein in skin. The claim therefore cannot be supported or refuted from the provided evidence.

### search_o1

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=7
- 回答(insufficient): The two retrieved excerpts concern IEX-1 induction by retinoic acids in NB4/KG1 leukemic cell lines and oxidative stress/depression-like behavior in leukemic Brown Norway rats; neither mentions RUNX nor skin tissue. No excerpt provides any positive or negative evidence about RUNX expression in skin, so the claim about tissue-specific expression cannot be assessed from this corpus.

### deepread

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(insufficient): None of the retrieved excerpts test whether RUNX is expressed in skin tissue. The only RUNX-related source [1982286] concerns RUNX1 as a tumor-suppressor mediator in T cell acute lymphoblastic leukemia, while the skin/epidermal source [2547636] discusses circadian clock genes in human epidermal stem cells without mentioning RUNX; [25238950] concerns FGF-2 in intestinal epithelium. The claim is therefore neither supported nor refuted by the given evidence.

## sf-011 — RUNX1 is downregulated or mutated in TLX1 T-ALL.

金标: 1982286

中间 Agent 排名: dense_rag_rerank(9.0) > itrg_refresh(9.0) > deepread(9.0) > qdcvr(9.0) > itrg_refine(8.0) > raptor(8.0) > search_o1(8.0) > dense_rag(7.0)

### qdcvr

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=10
- 回答(supported): Evidence [1982286] identifies RUNX1 as a key mediator of TLX1/TLX3-driven T-ALL and predicts a tumor-suppressor role for it in T-cell transformation, and reports recurrent somatic loss-of-function mutations in RUNX1 in human T-ALL. This directly supports RUNX1 being inactivated (loss-of-function mutated) in the TLX1 T-ALL context. The other excerpt [3113630] concerns ATM/HDAC4 in ataxia-telangiectasia and is irrelevant.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence reports that network analysis of the TLX1/TLX3 oncogenic circuit identified RUNX1 as a key mediator and predicted a tumor-suppressor role for it, and that recurrent somatic loss-of-function mutations in RUNX1 were identified in human T-ALL. This directly supports the 'mutated' arm of the claim; the excerpts do not themselves state downregulation of RUNX1 expression, but the disjunctive claim is satisfied by the reported mutations.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The abstract reports that network analysis identified RUNX1 as a key mediator of TLX1/TLX3-driven T-ALL and predicted a tumor-suppressor role, and they identified recurrent somatic loss-of-function mutations in RUNX1 in human T-ALL. This directly supports the 'mutated' component of the claim; explicit downregulation is not stated, but the 'or' condition is satisfied.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows reverse-engineering of the TLX1/TLX3 oncogenic network identified RUNX1 as a key mediator of TLX1/TLX3-induced T-ALL and predicted a tumor-suppressor role, which was confirmed by recurrent somatic loss-of-function RUNX1 mutations in human T-ALL. Thus the mutation arm of the disjunctive claim (downregulated or mutated) is directly established, though the excerpts do not explicitly report RUNX1 downregulation in TLX1 T-ALL.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The abstract reports that network analysis identified RUNX1 as a key mediator of TLX1/TLX3-driven T-ALL and predicted a tumor-suppressor role, and they identified recurrent somatic loss-of-function mutations in RUNX1 in human T-ALL. This directly supports the 'mutated' component of the claim; explicit downregulation is not stated, but the 'or' condition is satisfied.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Source [1982286] reports that network analysis of the TLX1/TLX3 oncogenic transcriptional circuit identified RUNX1 as a key mediator of TLX1- and TLX3-induced T-ALL and predicted a tumor-suppressor role for it in T cell transformation. Consistent with this, recurrent somatic loss-of-function RUNX1 mutations were identified in human T-ALL, supporting the claim that RUNX1 is inactivated/mutated in TLX1 T-ALL. The other two sources concern telomere biology and ataxia telangiectasia and are irrelevant.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence identifies RUNX1 as a key mediator of TLX1/TLX3-driven T-ALL and predicts a tumor-suppressor role for it in T cell transformation. It reports recurrent somatic loss-of-function mutations in RUNX1 in human T-ALL, directly supporting the mutation component of the claim within the TLX1 network context. Downregulation per se is not explicitly measured in the excerpt, but the tumor-suppressor prediction is consistent with it.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(supported): The evidence identifies RUNX1 as a key mediator of TLX1/TLX3-driven T-ALL and predicts a tumor-suppressor role for it in T cell transformation, consistent with its loss of function. It reports recurrent somatic loss-of-function mutations in RUNX1 in human T-ALL. Thus the claim that RUNX1 is inactivated (mutated, and functionally downregulated as a tumor suppressor) in TLX1 T-ALL is supported.

## sf-012 — Radioiodine treatment of non-toxic multinodular goitre increases thyroid volume.

金标: 9745001

中间 Agent 排名: itrg_refine(10.0) > dense_rag(10.0) > dense_rag_rerank(10.0) > itrg_refresh(10.0) > deepread(9.0) > search_o1(9.0) > qdcvr(9.0) > raptor(8.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The claim is contradicted by the retrieved evidence. In 45 patients with non-toxic multinodular goitre treated with a single dose of 131I, median thyroid volume fell from 73 ml (IQR 50-106) to 29 ml (IQR 23-48) at 24 months, a median reduction of 40 ml (60%, p < 0.0001), with half the reduction occurring within three months. Patients receiving two doses and those developing hypo- or hyperthyroidism also showed significant volume reduction, so radioiodine decreases rather than increases thyroid volume.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The retrieved evidence directly contradicts the claim: in 39 euthyroid patients treated with a single 131I dose, median ultrasonically determined thyroid volume fell from 73 (IQR 50-106) ml to 29 (23-48) ml at 24 months, a median reduction of 40 ml (60%, p < 0.0001), with half of the reduction occurring within three months. Radioiodine treatment therefore decreases, not increases, thyroid volume in non-toxic multinodular goitre.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The retrieved evidence directly contradicts the claim: in 39 euthyroid patients treated with a single 131I dose, median ultrasonically determined thyroid volume fell from 73 (IQR 50-106) ml to 29 (23-48) ml at 24 months, a median reduction of 40 ml (60%, p < 0.0001), with half of the reduction occurring within three months. Radioiodine treatment therefore decreases, not increases, thyroid volume in non-toxic multinodular goitre.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The evidence directly contradicts the claim: in 45 euthyroid patients treated with a single 131I dose, median thyroid volume fell from 73 ml (IQR 50-106) to 29 ml (23-48) at 24 months, a median reduction of 40 ml (60%, p < 0.0001). Patients receiving two doses and those developing hypo- or hyperthyroidism also showed significant volume reduction, so radioiodine decreases rather than increases thyroid volume in non-toxic multinodular goitre.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The retrieved evidence directly contradicts the claim: in 39 euthyroid patients treated with a single 131I dose, median ultrasonically determined thyroid volume fell from 73 (IQR 50-106) ml to 29 (23-48) ml at 24 months, a median reduction of 40 ml (60%, p < 0.0001), with half of the reduction occurring within three months. Radioiodine treatment therefore decreases, not increases, thyroid volume in non-toxic multinodular goitre.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The claim is contradicted by the evidence. In 39 euthyroid patients with non-toxic multinodular goitre treated with a single 131I dose, median thyroid volume fell from 73 ml (IQR 50-106) to 29 ml (23-48) at 24 months, a median reduction of 40 ml (60%, p < 0.0001), with half occurring within three months. Radioiodine therefore decreases, not increases, thyroid volume in this condition.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The evidence contradicts the claim: in 45 patients treated with a single 131I dose and remaining euthyroid, median thyroid volume fell from 73 ml to 29 ml at 24 months, a median reduction of 40 ml (60% reduction, p < 0.0001), with half occurring within three months. Radioiodine treatment of non-toxic multinodular goitre therefore reduces thyroid volume rather than increasing it.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The evidence directly contradicts the claim: in 45 patients treated with a single 131I dose who remained euthyroid, median thyroid volume fell from 73 ml (IQR 50-106) to 29 ml (23-48) at 24 months, a median reduction of 40 ml (60%, p < 0.0001), with half of that reduction within three months. Radioiodine therapy therefore decreases, rather than increases, thyroid volume in non-toxic multinodular goitre.

## sf-013 — Rapamycin delays aging in fruit flies.

金标: 6277638

中间 Agent 排名: search_o1(10.0) > raptor(10.0) > dense_rag_rerank(10.0) > dense_rag(9.0) > itrg_refresh(9.0) > itrg_refine(9.0) > qdcvr(9.0) > deepread(2.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Feeding rapamycin to adult Drosophila melanogaster extended life span, producing the longevity effect seen in some TOR mutants. The extension was mediated specifically through the TORC1 branch of the TOR pathway via altered autophagy and translation, and was accompanied by increased resistance to starvation and paraquat.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Evidence [6277638] directly reports that feeding rapamycin to adult Drosophila melanogaster produces life span extension comparable to that seen in some TOR mutants, with increased resistance to starvation and paraquat, acting specifically through the TORC1 branch via autophagy and translation. This establishes that rapamycin delays aging (extends life span) in fruit flies. The p38MAPK study [8519911] concerns mice and is not relevant to this claim.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The retrieved evidence directly reports that feeding rapamycin to adult Drosophila melanogaster produced life span extension comparable to that seen in some TOR mutants, with the effect mediated specifically through the TORC1 branch via altered autophagy and translation. Rapamycin-fed flies also showed increased resistance to starvation and paraquat, and the drug extended life span even in weak IIS-pathway mutants and in flies whose life span was already maximized by dietary restriction. This is direct experimental support for the claim that rapamycin delays aging in fruit flies.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Feeding rapamycin to adult Drosophila melanogaster extends life span, reproducing the longevity observed in some TOR mutants. The effect is mediated specifically through the TORC1 branch of the TOR pathway, via alterations to autophagy and translation, and is accompanied by increased resistance to starvation and paraquat. Rapamycin also extended life span in weak IIS pathway mutants and in flies whose life span was already maximized by dietary restriction, indicating additional mechanisms.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Evidence [6277638] directly reports that feeding rapamycin to adult Drosophila melanogaster produces life span extension comparable to that seen in some TOR mutants, with increased resistance to starvation and paraquat, acting specifically through the TORC1 branch via autophagy and translation. This establishes that rapamycin delays aging (extends life span) in fruit flies. The p38MAPK study [8519911] concerns mice and is not relevant to this claim.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The claim is supported. Feeding rapamycin to adult Drosophila melanogaster extends life span, producing the longevity effect seen in some TOR mutants. The mechanism operates specifically through the TORC1 branch, via alterations to autophagy and translation, and rapamycin also increased resistance to starvation and paraquat. The other two excerpts concern p38MAPK in mice and simvastatin in vein grafts, and are irrelevant to the claim.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The claim is supported: feeding rapamycin to adult Drosophila melanogaster produced the life span extension seen in some TOR mutants, with the increase associated with greater resistance to starvation and paraquat. The effect was shown to act specifically through the TORC1 branch of the TOR pathway via alterations in autophagy and translation. Lifespan extension also occurred in weak insulin/Igf signaling mutants and in flies already long-lived under dietary restriction, indicating additional mechanisms.

### deepread

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=2
- 回答(insufficient): No evidence excerpts were retrieved from the corpus, so the claim that rapamycin delays aging in fruit flies cannot be assessed against the provided sources. The retrieval returned an empty evidence set, leaving no data on rapamycin treatment, lifespan, or aging markers in Drosophila to support or refute the claim. A verdict of insufficient is therefore the only defensible conclusion under the constraint of using the supplied evidence alone.

## sf-014 — Rapamycin increases the concentration of triacylglycerols in fruit flies.

金标: 6277638

中间 Agent 排名: dense_rag_rerank(10.0) > raptor(10.0) > itrg_refine(9.0) > search_o1(9.0) > qdcvr(9.0) > dense_rag(8.0) > itrg_refresh(8.0) > deepread(7.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): The retrieved evidence establishes that feeding rapamycin to adult Drosophila extends life span via the TORC1 branch, with increased resistance to starvation and paraquat and alterations in autophagy and translation, but it never reports triacylglycerol (fat) concentrations. The second excerpt concerns histone H3(T118) phosphorylation and nucleosome dynamics and is unrelated to rapamycin or lipid levels in flies. Therefore the corpus excerpts neither support nor refute the claim that rapamycin increases triacylglycerol concentration in fruit flies.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(insufficient): The retrieved evidence establishes only that feeding rapamycin to adult Drosophila melanogaster extends life span, via the TORC1 branch, autophagy and translation, and increases resistance to starvation and paraquat. No excerpt reports triacylglycerol or lipid measurements in rapamycin-treated flies; the third source concerns catecholamines in lymphocytes and is unrelated. Therefore the claim that rapamycin increases triacylglycerol concentration in fruit flies is neither supported nor refuted by the provided evidence.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=7
- 回答(insufficient): The retrieved excerpts from [6277638] describe rapamycin feeding in Drosophila extending life span via TORC1, autophagy, translation, and increased starvation/paraquat resistance, but they contain no measurement or statement about triacylglycerol (TAG) concentration. Therefore the claim that rapamycin increases triacylglycerol concentration in fruit flies cannot be evaluated from this evidence.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): The retrieved excerpts describe rapamycin feeding to adult Drosophila extending life span via the TORC1 branch (autophagy and translation) and increasing resistance to starvation and paraquat. They contain no measurement or mention of triacylglycerol concentration in fruit flies. The claim about triacylglycerol levels is therefore not addressed by this evidence.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(insufficient): The provided excerpts mention that feeding rapamycin to adult Drosophila extends life span via TORC1, autophagy, and translation, but they contain no measurement or statement about triacylglycerol (fat) levels in fruit flies. The second excerpt concerns Mycobacterium tuberculosis and is unrelated. Therefore the claim cannot be assessed from this evidence.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(insufficient): The only rapamycin-in-Drosophila source [6277638] addresses life span extension, TORC1 signaling, autophagy, translation, and resistance to starvation and paraquat; it reports nothing about triacylglycerol levels in fruit flies. The other two excerpts concern lymphocyte catecholamines and metformin/AMPK lipid metabolism in rats and hepatocytes, neither of which tests rapamycin or triacylglycerols in Drosophila. No retrieved evidence therefore supports or refutes the claim.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): The retrieved excerpts do not address triacylglycerol concentration in fruit flies. Source [6277638] reports rapamycin-mediated life span extension in Drosophila via TORC1, autophagy, and translation, but says nothing about triacylglycerol or lipid levels; source [11742219] concerns hypothalamic galanin and dietary fat in rats, an unrelated organism and endpoint. No evidence in the provided text supports or refutes the claim.

### deepread

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=4
- 回答(insufficient): No evidence excerpts were retrieved from the corpus for this claim, so its relationship to rapamycin and triacylglycerol concentrations in fruit flies cannot be assessed. The claim is neither confirmed nor contradicted by the available material; a verdict requires at least one relevant passage reporting triacylglycerol measurements in rapamycin-treated Drosophila.

## sf-015 — Rapid phosphotransfer rates are correlated with histidine kinase regulator specificity.

金标: 11603066

中间 Agent 排名: raptor(10.0) > dense_rag(9.5) > search_o1(9.5) > itrg_refine(9.0) > dense_rag_rerank(8.5) > itrg_refresh(8.5) > qdcvr(8.5) > deepread(8.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Source 11603066 shows that specificity determinants in the CheA(3)-CheY(6) chemotaxis two-component system directly govern phosphotransfer: a cognate methionine finger on CheY(6) nestling into a hydrophobic pocket of CheA(3) is required for binding and phosphotransfer, its mutation abolished phosphotransfer, and introducing that methionine plus an adjacent alanine into noncognate CheYs dramatically changed their specificity to permit rapid phosphotransfer from CheA(3)-P. Thus rapid phosphotransfer is coupled to histidine kinase/response-regulator recognition specificity. Source 18987782 (Myc/ribosomal protein) is unrelated and provides no evidence on this claim.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): In the CheA(3)/CheY(6) chemotaxis two-component system, the structural determinants of regulator specificity (a methionine finger in CheY(6) nesting in a hydrophobic CheA(3) pocket, found only in cognate RRs CheY(6) and CheB(2)) directly govern phosphotransfer: mutating the methionine abolished binding and phosphotransfer from CheA(3)-P, while introducing the methionine plus an adjacent alanine into noncognate CheYs rewired specificity, enabling protein interaction and rapid phosphotransfer from CheA(3)-P. Thus rapid phosphotransfer accompanies cognate-specific regulator recognition.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows that a specific structural determinant (a methionine finger on CheY6 that fits a hydrophobic pocket in CheA3, present only in cognate response regulators) is required for binding and rapid phosphotransfer from CheA3-P. Mutating it abolished binding and phosphotransfer, while grafting the methionine plus adjacent alanine into noncognate CheYs changed their specificity and allowed protein interaction and rapid phosphotransfer from CheA3-P. Thus rapid phosphotransfer correlates with, and is gated by, cognate histidine kinase-response regulator specificity.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Evidence [11603066] shows that phosphotransfer specificity in the CheA-CheY two-component pathway is determined by a methionine finger on the cognate response regulator; site-directed mutagenesis abolishing this determinant also abolished phosphotransfer, while introducing the methionine plus adjacent alanine into noncognate CheYs 'dramatically changed their specificity, allowing protein interaction and rapid phosphotransfer from CheA(3)-P.' Thus rapid phosphotransfer tracks the presence of the cognate specificity determinants, supporting a correlation between rapid phosphotransfer rates and histidine kinase-regulator specificity. Evidence [19966976] concerns HP1/Swi6 heterochromatin phosphorylation and is irrelevant to this claim.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows that a specific structural determinant (a methionine finger on CheY6 that fits a hydrophobic pocket in CheA3, present only in cognate response regulators) is required for binding and rapid phosphotransfer from CheA3-P. Mutating it abolished binding and phosphotransfer, while grafting the methionine plus adjacent alanine into noncognate CheYs changed their specificity and allowed protein interaction and rapid phosphotransfer from CheA3-P. Thus rapid phosphotransfer correlates with, and is gated by, cognate histidine kinase-response regulator specificity.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The CheA(3)/CheY(6) chemotaxis study shows that specificity is structurally encoded: a methionine finger (with an adjacent alanine) present only in cognate regulators mediates complex formation and enables rapid phosphotransfer from CheA(3)-P, and transplanting these residues into noncognate CheYs both changed their specificity and allowed rapid phosphotransfer. This directly links histidine kinase/response-regulator specificity determinants to rapid phosphotransfer. The two histone-phosphorylation excerpts concern chromatin regulation and provide no relevant evidence.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Evidence [11603066] shows that phosphotransfer specificity in the CheA(3)/CheY(6) two-component system is governed by a methionine finger on the cognate response regulator, and that introducing this methionine plus an adjacent alanine into noncognate CheYs dramatically changed their specificity while allowing rapid phosphotransfer from CheA(3)-P. Thus the determinant of regulator specificity is also the determinant of rapid phosphotransfer, consistent with a correlation between rapid phosphotransfer rates and histidine kinase regulator specificity. The other two sources concern chromatin/histone phosphorylation and provide no relevant support.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence directly links specificity determinants of the CheA(3)-CheY(6) interaction to phosphotransfer efficiency: a cognate methionine finger plus adjacent alanine was required for binding, and introducing these residues into noncognate CheYs dramatically changed their specificity, enabling protein interaction and rapid phosphotransfer from CheA(3)-P. Mutagenesis of the methionine and two adjacent residues abolished both binding and phosphotransfer. Thus, rapid phosphotransfer is correlated with (governed by the same determinants as) histidine kinase regulator specificity.

## sf-016 — Recognition of start codons depends on the translation initiation factor IF3.

金标: 16927286

中间 Agent 排名: search_o1(10.0) > dense_rag_rerank(10.0) > deepread(9.0) > raptor(9.0) > itrg_refresh(9.0) > itrg_refine(8.0) > qdcvr(8.0) > dense_rag(8.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Evidence from cryoEM reconstructions of the bacterial 30S initiation complex shows that IF3, together with initiator tRNA, undergoes large conformational changes that facilitate accommodation of fMet-tRNA(fMet) into the P site for start codon recognition, indicating IF3 is directly involved in this process. The claim is therefore supported by source 16927286. Source 18987782 concerns Myc-driven translation initiation and ribosomal protein haploinsufficiency and provides no information on start codon recognition or IF3.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Evidence from cryoEM reconstructions of the bacterial 30S initiation complex shows that IF3, together with initiator tRNA, undergoes large conformational changes that facilitate accommodation of fMet-tRNA(fMet) into the P site for start codon recognition. This directly links IF3 activity to the start codon recognition step of bacterial translation initiation. The second excerpt concerns Myc-driven translation initiation and provides no information bearing on this claim.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): IF3 is directly implicated in start codon recognition: the cryoEM reconstructions show that IF3 and tRNA undergo large conformational changes that facilitate accommodation of fMet-tRNA(fMet) into the P site for start codon recognition, and IFs 1-3 together enable selection of the initiator tRNA and the start codon in the P site of the 30S subunit. IF1 anchors IF2 and IF3 to enhance their activities, placing IF3 within the initiation pathway that reads the start codon. The Myc/ribosomal-protein-haploinsufficiency excerpt is unrelated to IF3 function.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence states that bacterial translation initiation requires initiation factors IF1–IF3 to select the initiator tRNA and start codon in the 30S subunit P site, and that IF3 (together with tRNA) undergoes large conformational changes enabling accommodation of fMet-tRNA(fMet) into the P site for start codon recognition. IF1 also provides anchoring points for IF3 that enhance its activity. Thus the corpus directly attributes start codon recognition with IF3 involvement.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The IF3 cryoEM study states that IF3 (together with tRNA) undergoes large conformational changes that facilitate accommodation of fMet-tRNA(fMet) into the P site for start codon recognition, directly linking IF3 to start codon recognition. The yeast RPL32 excerpt is unrelated to initiation factor function and contributes no support. Thus the claim is supported by the bacterial initiation evidence.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Source 16927286 reports cryoEM reconstructions of the bacterial 30S initiation complex with initiator tRNA, mRNA, and IFs 1-3 at successive steps of the initiation pathway, and states that IF3 (together with tRNA) undergoes large conformational changes to facilitate accommodation of fMet-tRNA into the P site for start codon recognition. This directly links IF3 to the start codon recognition step. The Myc and diffusion-MRI sources are unrelated to initiation-factor-dependent start codon recognition.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The excerpt states that IF3, together with tRNA, undergoes large conformational changes that facilitate accommodation of fMet-tRNA(fMet) into the P site for start codon recognition. This directly indicates that start codon recognition depends on IF3. Note the evidence describes IF3 acting in concert with tRNA and the other initiation factors (IF1, IF2) rather than as a sole determinant.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence states that the three initiation factors (IFs 1-3) enable start-codon selection, and specifically that IF3 (together with tRNA) undergoes large conformational changes to facilitate accommodation of fMet-tRNA(fMet) into the P site for start codon recognition. Thus the corpus directly attributes a role in start codon recognition to IF3.

## sf-017 — Reduced levels of lipolysis leads to higher P38 phosphorylation in adipose tissue.

金标: 32408470

中间 Agent 排名: deepread(10.0) > dense_rag(10.0) > dense_rag_rerank(10.0) > itrg_refine(10.0) > raptor(10.0) > search_o1(10.0) > qdcvr(8.0) > itrg_refresh(7.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(insufficient): The retrieved evidence (32408470) describes the opposite causal direction: nicotine-driven AMPKα2 activation degrades MKP1, which aberrantly activates p38 MAPK and JNK, and this p38 activation leads to IRS1 degradation and loss of insulin-mediated inhibition of lipolysis, i.e., increased lipolysis. No excerpt tests whether reduced lipolysis raises p38 phosphorylation, and source 3113630 concerns HDAC4/ATM in neurons and is irrelevant. The claim's stated direction is therefore neither demonstrated nor directly refuted by the provided evidence.

### dense_rag

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(refuted): The only adipose-relevant evidence [32408470] establishes the opposite directionality: nicotine-induced AMPKα2 activation causes MKP1 degradation, which increases p38 phosphorylation, and that p38 activation drives IRS1 Ser307 phosphorylation, IRS1 degradation, and loss of insulin-mediated inhibition of lipolysis — i.e., elevated p38 phosphorylation increases lipolysis. No excerpt reports adipose lipolysis levels regulating p38 phosphorylation, and the retrieved p38MAPK paper [8519911] concerns islet cell cycle inhibitors, not lipolysis. The claim's implied relationship is therefore contradicted by the causal chain in the corpus.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(refuted): The corpus evidence describes the opposite directionality: nicotine-driven MKP1 degradation causes aberrant activation of p38 MAPK, which via IRS1 Ser307 phosphorylation blocks insulin-mediated inhibition of lipolysis and thereby increases lipolysis. Thus higher p38 phosphorylation is upstream of increased lipolysis, not a consequence of reduced lipolysis; the claim reverses this causal order and is unsupported by any excerpt linking reduced lipolysis to elevated p38 phosphorylation.

### raptor

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(refuted): The only relevant evidence describes the opposite causal direction: in adipocytes, nicotine-driven AMPKα2 activation degrades MKP1, causing aberrant p38 MAPK activation that inhibits insulin signaling and thereby increases lipolysis, not the reverse. No evidence supports reduced lipolysis raising p38 phosphorylation in adipose tissue; the cited aging/p38 islet study concerns neither lipolysis nor adipose tissue.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(insufficient): The evidence describes the reverse relationship: nicotine-driven MKP1 degradation causes aberrant p38 MAPK activation, which increases IRS1 serine 307 phosphorylation, impairs insulin-mediated inhibition of lipolysis, and thereby increases lipolysis. Nothing in the excerpt tests whether reduced lipolysis raises p38 phosphorylation in adipose tissue; if anything, the reported chain places p38 activation upstream of elevated lipolysis, not downstream of suppressed lipolysis. The claim's directionality is therefore unsupported by this source.

### itrg_refine

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=10
- 回答(refuted): The only relevant evidence shows the opposite causal direction: in adipocytes, nicotine-induced activation of AMPKα2 degrades MKP1, causing aberrant p38 MAPK activation, which drives IRS1 Ser307 phosphorylation and insulin-resistance-associated loss of insulin-mediated inhibition of lipolysis, thereby increasing lipolysis. Thus increased p38 phosphorylation promotes elevated lipolysis, not the reverse. No evidence indicates that reduced lipolysis raises p38 phosphorylation.

### search_o1

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=10
- 回答(refuted): The corpus evidence describes the opposite causal direction: nicotine-driven degradation of MKP1 induces p38 MAPK (and JNK) activation, which increases IRS1 serine-307 phosphorylation, impairs insulin-mediated suppression of lipolysis, and thereby elevates lipolysis. Higher P38 phosphorylation thus drives increased lipolysis in adipose tissue, rather than reduced lipolysis raising P38 phosphorylation. No excerpt supports the claim as stated.

### deepread

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=10
- 回答(refuted): The retrieved evidence establishes the opposite causal direction: nicotine-induced degradation of MKP1 causes aberrant p38 MAPK (and JNK) activation, which drives IRS1 serine-307 phosphorylation, PKB inhibition, and loss of insulin-mediated inhibition of lipolysis, thereby increasing lipolysis in adipocytes (32408470). Thus p38 phosphorylation is presented as an upstream cause of elevated lipolysis, not a consequence of reduced lipolysis. No excerpt shows reduced lipolysis raising p38 phosphorylation.

## sf-018 — Reduced phosphorylation of PP2A increases HDAC4 dephosphorylation by enhancing PP2A-HDAC4 interaction.

金标: 3113630

中间 Agent 排名: dense_rag(10.0) > raptor(10.0) > itrg_refresh(9.0) > search_o1(9.0) > itrg_refine(9.0) > deepread(8.0) > dense_rag_rerank(8.0) > qdcvr(5.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(supported): Source [3113630] states that PP2A activity is downregulated by ATM-mediated phosphorylation, and that in ATM deficiency (i.e., loss of that inhibitory phosphorylation) enhanced PP2A activity leads to HDAC4 dephosphorylation and nuclear accumulation. This supports the core claim that reduced PP2A phosphorylation increases HDAC4 dephosphorylation. However, the evidence attributes this to increased PP2A catalytic activity, not specifically to enhanced PP2A-HDAC4 interaction, which is not addressed. Source [19966976] concerns HP1/Swi6 phosphorylation in heterochromatin and is irrelevant.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): Source [3113630] supports the directional core: PP2A activity is downregulated by ATM-mediated phosphorylation, so reduced PP2A phosphorylation yields enhanced PP2A activity that leads to HDAC4 dephosphorylation and nuclear accumulation. However, the evidence attributes this to increased PP2A catalytic activity, not to enhanced PP2A-HDAC4 interaction; no retrieval excerpt addresses whether the phosphatase-substrate interaction is strengthened. The interaction mechanism asserted in the claim is therefore unverified by the provided evidence.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(insufficient): The evidence supports only part of the claim: PP2A activity is downregulated by ATM-mediated phosphorylation, and in ATM deficiency enhanced PP2A activity leads to HDAC4 dephosphorylation and nuclear accumulation of HDAC4. Thus reduced PP2A phosphorylation is consistent with increased HDAC4 dephosphorylation via elevated PP2A activity. However, the excerpts contain no statement that this occurs by enhancing PP2A-HDAC4 interaction, so that specific mechanistic element is unsupported.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(insufficient): The evidence supports the directional core of the claim: ATM-mediated phosphorylation downregulates PP2A, and in ATM deficiency (i.e., reduced PP2A phosphorylation) enhanced PP2A activity dephosphorylates HDAC4, driving its nuclear accumulation. However, no excerpt states that this occurs by enhancing a physical PP2A-HDAC4 interaction; the interaction mechanism is asserted in the claim but absent from the retrieved evidence. The claim is therefore only partially grounded and the proposed mechanism remains unverified.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(insufficient): Evidence [3113630] supports the causal direction: ATM-mediated phosphorylation downregulates PP2A, and in ATM deficiency enhanced PP2A activity leads to HDAC4 dephosphorylation and nuclear accumulation. However, the claim's stated mechanism — that reduced PP2A phosphorylation increases HDAC4 dephosphorylation specifically by enhancing PP2A–HDAC4 interaction — is not described anywhere in the retrieved evidence. Source [12948892] is unrelated (AMPA receptor/Akt in glioblastoma) and contributes nothing.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): Source [3113630] supports the directional core: PP2A activity is downregulated by ATM-mediated phosphorylation, so reduced PP2A phosphorylation yields enhanced PP2A activity that leads to HDAC4 dephosphorylation and nuclear accumulation. However, the evidence attributes this to increased PP2A catalytic activity, not to enhanced PP2A-HDAC4 interaction; no retrieval excerpt addresses whether the phosphatase-substrate interaction is strengthened. The interaction mechanism asserted in the claim is therefore unverified by the provided evidence.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(insufficient): Evidence [3113630] supports the upstream and downstream halves of the claim: ATM-mediated phosphorylation downregulates PP2A activity, and in ATM deficiency enhanced PP2A activity leads to HDAC4 dephosphorylation (with nuclear accumulation). However, the stated mechanism — that reduced PP2A phosphorylation increases HDAC4 dephosphorylation specifically by enhancing PP2A-HDAC4 interaction — is not addressed; no excerpt reports PP2A-HDAC4 binding or that phosphorylation of PP2A modulates such an interaction. The claim's causal direction is consistent with the corpus, but its proposed interaction mechanism is unsupported.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(insufficient): Evidence [3113630] supports the upstream link: ATM-mediated phosphorylation downregulates PP2A activity, and in ATM deficiency enhanced PP2A activity leads to HDAC4 dephosphorylation and nuclear accumulation — consistent with reduced PP2A phosphorylation increasing HDAC4 dephosphorylation. However, the proposed mechanism ('by enhancing PP2A-HDAC4 interaction') is not stated or tested in the evidence; only altered PP2A activity is reported, not a change in PP2A-HDAC4 binding. Source [29788648] concerns NuA4 acetylation and is irrelevant. The interaction-dependent mechanism is therefore unsupported.

## sf-019 — Reduced phosphorylation of PP2A suppresses HDAC4 dephosphorylation.

金标: 3113630

中间 Agent 排名: itrg_refresh(10.0) > deepread(10.0) > dense_rag_rerank(10.0) > qdcvr(10.0) > search_o1(10.0) > dense_rag(10.0) > itrg_refine(10.0) > raptor(9.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The evidence indicates PP2A activity is downregulated by ATM-mediated phosphorylation, so reduced PP2A phosphorylation would enhance, not suppress, PP2A activity. In ATM deficiency, enhanced PP2A activity leads to HDAC4 dephosphorylation and nuclear accumulation; thus reduced PP2A phosphorylation promotes rather than suppresses HDAC4 dephosphorylation, inverting the claim.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The claim inverts the relationship shown in source 3113630. There, PP2A activity is downregulated by ATM-mediated phosphorylation of PP2A, so reduced PP2A phosphorylation would relieve that inhibition and increase PP2A activity, thereby promoting—not suppressing—HDAC4 dephosphorylation and nuclear accumulation. The evidence indicates phosphorylation of PP2A suppresses HDAC4 dephosphorylation, whereas reduced phosphorylation of PP2A enhances it.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The evidence states that PP2A activity is downregulated by ATM-mediated phosphorylation, so reduced PP2A phosphorylation would raise PP2A activity, not lower it. Consistently, in ATM deficiency (where PP2A phosphorylation is reduced) enhanced PP2A activity leads to HDAC4 dephosphorylation and nuclear accumulation. Thus reduced phosphorylation of PP2A promotes, rather than suppresses, HDAC4 dephosphorylation.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The evidence states that ATM-mediated phosphorylation downregulates PP2A activity, and that in ATM deficiency enhanced PP2A activity leads to HDAC4 dephosphorylation and nuclear HDAC4 accumulation. Thus reduced PP2A phosphorylation would increase PP2A activity and promote, not suppress, HDAC4 dephosphorylation, so the claim inverts the described relationship.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The claim contradicts the retrieved evidence. Source [3113630] states that PP2A activity is downregulated by ATM-mediated phosphorylation, so reduced phosphorylation of PP2A would raise its phosphatase activity and thereby promote (not suppress) HDAC4 dephosphorylation and nuclear accumulation. Source [12948892] concerns AMPA-receptor/Akt signaling in glioblastoma and provides no relevant support.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The claim inverts the relationship shown in source 3113630. There, PP2A activity is downregulated by ATM-mediated phosphorylation of PP2A, so reduced PP2A phosphorylation would relieve that inhibition and increase PP2A activity, thereby promoting—not suppressing—HDAC4 dephosphorylation and nuclear accumulation. The evidence indicates phosphorylation of PP2A suppresses HDAC4 dephosphorylation, whereas reduced phosphorylation of PP2A enhances it.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The evidence states that PP2A activity is downregulated by ATM-mediated phosphorylation, so reduced phosphorylation of PP2A would increase (not decrease) its phosphatase activity. In ATM deficiency, enhanced PP2A activity leads to HDAC4 dephosphorylation and nuclear accumulation of HDAC4, indicating that reduced PP2A phosphorylation promotes HDAC4 dephosphorylation rather than suppressing it.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The evidence states that ATM-mediated phosphorylation downregulates PP2A activity, so reduced PP2A phosphorylation would increase PP2A activity and thereby promote, not suppress, HDAC4 dephosphorylation. In ATM deficiency, enhanced PP2A activity leads to HDAC4 dephosphorylation and nuclear accumulation, the opposite of the claim's direction. The claim inverts the stated relationship.

## sf-020 — Reduced responsiveness to interleukin-2 in regulatory T cells is associated with autoimmune diseases such as Type 1 Diabetes.

金标: 11899391, 13923140

中间 Agent 排名: deepread(10.0) > dense_rag_rerank(9.0) > itrg_refresh(9.0) > qdcvr(9.0) > itrg_refine(9.0) > raptor(8.0) > dense_rag(8.0) > search_o1(8.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Source [11899391] directly supports the claim: an autoimmune disease-associated IL2RA haplotype (linked to type 1 diabetes) correlates with diminished IL-2 responsiveness in CD4+ T cells (reduced STAT5a phosphorylation), lower FOXP3 expression in Tregs, and reduced suppressive function, while Tregs from type 1 diabetes and other autoimmune patients are deficient in controlling autologous proinflammatory responses. Source [13923140] corroborates the broader link between impaired IL-2/IL-2 pathway and reduced CD4+CD25+ Treg function causing autoimmunity, though it concerns reduced IL-2 production rather than Treg responsiveness specifically.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The claim is supported: an autoimmune disease-associated IL2RA haplotype correlated with diminished IL-2 responsiveness (reduced STAT5a phosphorylation) in Ag-experienced CD4+ T cells, lower FOXP3 expression in Tregs, and reduced suppressive capacity, in studies using healthy human subjects to avoid disease confounds. Corroborating mouse evidence shows that reduced IL-2 production via Idd3/Il2 susceptibility alleles correlates with reduced CD4+CD25+ regulatory T cell function. Treg dysfunction is thus linked to IL-2/IL-2 signaling defects and to Type 1 Diabetes-associated variants.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows that a type 1 diabetes-associated IL2RA haplotype correlates with diminished IL-2 responsiveness, as measured by STAT5a phosphorylation, and is linked to reduced FOXP3 expression and impaired suppressive function in CD4+CD25+ regulatory T cells. It further notes that Tregs from individuals with a range of autoimmune diseases, including type 1 diabetes, are deficient in controlling autologous proinflammatory responses. This directly supports the claim that reduced IL-2 responsiveness in Tregs is associated with autoimmune diseases such as type 1 diabetes.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(supported): Evidence [11899391] shows that a type 1 diabetes-associated IL2RA haplotype correlates with diminished IL-2 responsiveness (reduced STAT5a phosphorylation), lower FOXP3 expression in Tregs, and reduced Treg suppressive capacity, linking reduced IL-2 signaling to T1D risk. Complementarily, [13923140] shows in mice that reduced IL-2 availability correlates with reduced CD4+CD25+ regulatory T cell function and autoimmune dysregulation, so the claim that impaired IL-2 responsiveness/availability in Tregs is associated with autoimmune diseases such as Type 1 Diabetes is supported.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The corpus supports the claim. Carriage of a type 1 diabetes-associated IL2RA haplotype correlates with diminished IL-2 responsiveness (reduced STAT5a phosphorylation) in Ag-experienced CD4+ T cells and is associated with lower FOXP3 expression and impaired suppressive function of CD4+CD25+ regulatory T cells; Tregs from autoimmune individuals, including type 1 diabetes, are reported deficient in controlling autologous proinflammatory responses. Complementary evidence in mice shows that reduced IL-2 production correlates with reduced CD4+CD25+ Treg function and accompanies autoimmune dysregulation. Thus diminished IL-2 responsiveness/signaling in Tregs is associated with autoimmune disease including type 1 diabetes.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Evidence 11899391 directly shows that a Type 1 diabetes-associated IL2RA haplotype correlates with diminished IL-2 responsiveness (reduced STAT5a phosphorylation) in CD4+ T cells and lower FOXP3 expression with reduced suppressive capacity in CD4+CD25+ Tregs, establishing the association in humans. Evidence 13923140 independently links reduced IL-2 (via Il2 haplodeficiency or Idd3 susceptibility alleles) to diminished CD4+CD25+ regulatory T cell function and autoimmune dysregulation in mice, corroborating the Treg/IL-2 axis in autoimmunity, though it addresses IL-2 production rather than responsiveness.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(supported): The corpus supports the claim: an autoimmune disease-associated IL2RA haplotype correlates with diminished IL-2 responsiveness (reduced STAT5a phosphorylation) and diminished CD4+CD25+ Treg suppressive function in healthy human subjects, avoiding disease confounding. Additionally, genetically reduced IL-2 availability correlates with reduced CD4+CD25+ Treg function and autoimmune dysregulation in mice. Both lines link impaired IL-2 signaling in Tregs to autoimmunity, including Type 1 Diabetes.

### deepread

- 指标: hit@1=1.000 R@5=0.500 nDCG@10=0.613 judge=8
- 回答(supported): The evidence reports that Tregs from individuals with human autoimmune diseases including type 1 diabetes are deficient in suppressing autologous proinflammatory responses, and that an autoimmune-disease-associated IL2RA haplotype correlates with diminished IL-2 responsiveness (reduced STAT5a phosphorylation), lower FOXP3 expression in Tregs, and reduced suppressive capacity. Because IL2RA encodes the IL-2 receptor alpha chain and this haplotype confers higher autoimmune disease risk, the findings directly link reduced IL-2 responsiveness to Treg dysfunction in Type 1 Diabetes. The claim is therefore supported, though the IL-2 responsiveness measurement was made in antigen-experienced CD4+ T cells rather than Tregs alone.

## sf-021 — Reducing H3k4me3 methylation induces mouse epiblast stem cells to naive pluripotency efficiently.

金标: 6441369

中间 Agent 排名: search_o1(10.0) > itrg_refine(10.0) > dense_rag(9.0) > itrg_refresh(9.0) > raptor(9.0) > dense_rag_rerank(9.0) > deepread(9.0) > qdcvr(8.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Evidence [6441369] shows that blocking the H3K4 methyltransferase MLL1 with MM-401 — thereby reducing H3K4 methylation — reprograms mouse epiblast stem cells (EpiSCs) to naive pluripotency, with more than 50% of treated cells acquiring naive ESC features within 3 days, an efficiency the authors describe as highly efficient and synchronized. The reverted cells reactivate the silenced X chromosome and generate germline-competent chimeras, and the authors conclude that discrete perturbation of H3K4 methylation suffices to drive reprogramming to naive pluripotency. The excerpt specifically reports H3K4me1 redistribution at enhancers rather than H3K4me3 levels, but MLL1 is an H3K4 methyltransferase, consistent with the claim's mechanism. Source [8185080] concerns HDAC/DNMT inhibitors in somatic-cell reprogramming and is irrelevant.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows that pharmacological blockade of the H3K4 methyltransferase MLL1 with MM-401 reprograms mouse EpiSCs to naive pluripotency efficiently (>50% acquire naive ESC features within 3 days, reactivate the silenced X chromosome, and yield germline-competent chimeras). The abstract concludes that discrete perturbation of H3K4 methylation is sufficient to drive reprogramming to naive pluripotency, consistent with the claim. Note the mechanistic detail given is a global redistribution of H3K4me1 at enhancers and repression of lineage/EpiSC determinants; the excerpt does not explicitly quantify reduced H3K4me3, so the support is for H3K4-methylation perturbation via MLL1 inhibition rather than a directly measured H3K4me3 decrease.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows that blocking the H3K4 methyltransferase MLL1 with MM-401 reprograms mouse epiblast stem cells (EpiSCs) to naive pluripotency highly efficiently and synchronously (>50% within 3 days), with reverted cells reactivating the silenced X chromosome and contributing to germline-competent chimeras. The source explicitly concludes that discrete perturbation of H3K4 methylation is sufficient to drive reprogramming to naive pluripotency. Note the excerpt specifies H3K4 methylation/MLL1 inhibition and H3K4me1 redistribution at enhancers rather than explicitly naming H3K4me3 reduction.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows that pharmacological blockade of the H3K4 methyltransferase MLL1 with MM-401 reprograms mouse EpiSCs to naive pluripotency efficiently (>50% acquire naive ESC features within 3 days, reactivate the silenced X chromosome, and yield germline-competent chimeras). The abstract concludes that discrete perturbation of H3K4 methylation is sufficient to drive reprogramming to naive pluripotency, consistent with the claim. Note the mechanistic detail given is a global redistribution of H3K4me1 at enhancers and repression of lineage/EpiSC determinants; the excerpt does not explicitly quantify reduced H3K4me3, so the support is for H3K4-methylation perturbation via MLL1 inhibition rather than a directly measured H3K4me3 decrease.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows that pharmacological blockade of the H3K4 methyltransferase MLL1 with MM-401 reprograms mouse EpiSCs to naive pluripotency efficiently (>50% acquire naive ESC features within 3 days, reactivate the silenced X chromosome, and yield germline-competent chimeras). The abstract concludes that discrete perturbation of H3K4 methylation is sufficient to drive reprogramming to naive pluripotency, consistent with the claim. Note the mechanistic detail given is a global redistribution of H3K4me1 at enhancers and repression of lineage/EpiSC determinants; the excerpt does not explicitly quantify reduced H3K4me3, so the support is for H3K4-methylation perturbation via MLL1 inhibition rather than a directly measured H3K4me3 decrease.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(supported): The claim is supported: blocking the H3K4 methyltransferase MLL1 with MM-401 reprograms mouse epiblast stem cells (EpiSCs) to naive pluripotency efficiently, with >50% of treated EpiSCs showing naive ESC features within 3 days and yielding germline-competent chimeras. The study concludes that discrete perturbation of H3K4 methylation is sufficient to drive reprogramming to naive pluripotency, though it attributes the effect mechanistically to global H3K4me1 redistribution at enhancers and repression of lineage determinants rather than to H3K4me3 reduction specifically.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence supports that inhibiting the H3K4 methyltransferase MLL1 with MM-401 efficiently reprograms mouse EpiSCs to naive pluripotency, with >50% of treated cells showing naive ESC features within 3 days and forming germline-competent chimeras. However, the excerpt attributes the effect to global redistribution of H3K4me1 at enhancers and a general perturbation of H3K4 methylation rather than explicitly to reduction of H3K4me3, so the claim's efficiency is confirmed while the specific mark named (H3K4me3) is not directly established by this evidence.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence directly supports the claim: inhibiting the H3K4 methyltransferase MLL1 with MM-401 reprograms mouse epiblast stem cells (EpiSCs) to naive pluripotency, with more than 50% of treated EpiSCs acquiring naive ESC features within 3 days, which the authors describe as highly efficient and synchronized. The reverted cells reactivate the silenced X chromosome and generate germline-competent chimeras, and the authors conclude that discrete perturbation of H3K4 methylation is sufficient to drive reprogramming to naive pluripotency. Note the evidence specifically frames the mechanism as blocking MLL1 activity (with global redistribution of H3K4me1 at enhancers), so the claim's phrasing 'reducing H3K4me3 methylation' is a reasonable but slightly narrower gloss on the demonstrated MLL1/H3K4-methylation perturbation.

## sf-022 — Reduction of Rpl38 alters the composition of the Hox gene mRNAs translation in mice without lowering overall protein synthesis.

金标: 12486491

中间 Agent 排名: deepread(10.0) > search_o1(10.0) > raptor(10.0) > qdcvr(9.0) > itrg_refresh(9.0) > dense_rag_rerank(9.0) > itrg_refine(9.0) > dense_rag(9.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Evidence [12486491] directly confirms the claim: in Rpl38 mutant mouse embryos, global protein synthesis is unchanged while translation of a select subset of Homeobox (Hox) mRNAs is perturbed, with RPL38 acting as a regulatory component facilitating 80S complex formation on these transcripts to confer transcript-specific translational control. This establishes that reduced Rpl38 alters the translational composition of Hox mRNAs without lowering overall protein synthesis. The Myc study [18987782] concerns ribosomal protein haploinsufficiency and general translation in oncogenesis and is not needed to support the claim.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): Source 12486491 reports that Rpl38 mutant mouse embryos show unchanged global protein synthesis while translation of a select subset of Homeobox mRNAs is perturbed, with RPL38 facilitating 80S complex formation on those mRNAs to confer transcript-specific control. This directly matches the claim that reduced Rpl38 alters Hox mRNA translation composition without lowering overall protein synthesis. Source 8519911 concerns p38MAPK and islet proliferation in aging and is not relevant.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The Rpl38 study (source 12486491) directly reports that in Rpl38 mutant mouse embryos global protein synthesis is unchanged, while the translation of a select subset of Homeobox (Hox) mRNAs is perturbed, with RPL38 facilitating 80S complex formation on these transcripts to confer transcript-specific translational control. Thus reduction of Rpl38 alters the translational composition/selectivity of Hox mRNAs without lowering overall protein synthesis, matching the claim. Source 18987782 concerns Myc-driven protein synthesis and is not relevant to Rpl38.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence states that Rpl38 mutant mouse embryos show unchanged global protein synthesis while translation of a select subset of Homeobox mRNAs is perturbed, with RPL38 facilitating 80S complex formation on these mRNAs to confer transcript-specific control. This matches the claim that reducing Rpl38 alters translation of Hox gene mRNAs in mice without lowering overall protein synthesis, though the evidence frames it as a subset of Homeobox (Hox) transcripts rather than all Hox mRNAs.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The Rpl38 mutant mouse study reports that while global protein synthesis is unchanged in Rpl38 mutant embryos, the translation of a select subset of Homeobox (Hox) mRNAs is perturbed, consistent with transcript-specific translational control. RPL38 is shown to facilitate 80S complex formation on these mRNAs as a regulatory ribosomal component. Thus the evidence directly supports the claim that reduced Rpl38 alters Hox mRNA translation without lowering overall protein synthesis.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): In Rpl38 mutant mouse embryos, global protein synthesis is unchanged, yet the translation of a select subset of Homeobox (Hox) mRNAs is perturbed, with RPL38 facilitating 80S complex formation on these mRNAs to confer transcript-specific translational control. This directly matches the claim that Rpl38 reduction alters Hox mRNA translation composition without lowering overall protein synthesis. The other excerpts concern p38MAPK signaling and Myc-driven translation and do not bear on Rpl38.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(supported): The evidence shows that Rpl38 mutant mouse embryos have unchanged global protein synthesis while the translation of a select subset of Homeobox (Hox) mRNAs is perturbed, with RPL38 facilitating 80S complex formation on these transcripts to confer transcript-specific translational control. Thus reduced Rpl38 function selectively alters Hox mRNA translation without lowering overall protein synthesis.

### deepread

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=10
- 回答(supported): Loss of Rpl38 in mouse embryos leaves global protein synthesis unchanged while perturbing translation of a select subset of Homeobox (Hox) mRNAs, so the claim is directly supported. The reported mechanism is that RPL38 acts as a regulatory ribosome component facilitating 80S complex formation on these specific mRNAs, conferring transcript-specific translational control.

## sf-023 — Reduction of purity of cytoplasmic membranes isolated from overexpressors is indicated by stronger spots for OmpA in 2D BN-PAGE gels.

金标: 6836086

中间 Agent 排名: dense_rag_rerank(10.0) > itrg_refine(9.0) > itrg_refresh(9.0) > raptor(9.0) > dense_rag(8.5) > qdcvr(8.0) > search_o1(8.0) > deepread(7.5)

### qdcvr

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=4
- 回答(insufficient): The provided evidence is unrelated to the claim: both excerpts concern cytoplasmic Ca2+ oscillations/CRAC channel signaling and WFS1-AC8 interaction at the plasma membrane, with no mention of OmpA, 2D BN-PAGE, membrane purity, or overexpression. No excerpt reports spot intensity for OmpA or any membrane-purity marker, so the claim cannot be evaluated. Additional source material on OmpA detection in BN-PAGE of cytoplasmic membrane preparations is required.

### dense_rag

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(insufficient): None of the three retrieved excerpts address the claim: no excerpt mentions OmpA, 2D BN-PAGE, membrane-purity measurements, or overexpressor strains. Excerpt [6836086] concerns the E. coli outer-membrane protein assembly complex (YfgL/Bam components) but reports only genetic interactions with imp/LPS assembly, not membrane purity or OmpA spot intensity in BN-PAGE. The claim therefore cannot be evaluated from the provided evidence.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=7
- 回答(insufficient): None of the three evidence excerpts address the claim: they concern outer membrane biogenesis in E. coli, Sestrin2/Ucp1 regulation, and WFS1/AC8 insulin secretion. No excerpt mentions OmpA, 2D BN-PAGE gels, cytoplasmic membrane isolation, overexpressors, or membrane purity, so the claim cannot be assessed from the provided evidence.

### raptor

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=8
- 回答(insufficient): None of the retrieved excerpts addresses the claim. The desmosome/hemidesmosome carcinoma paper [22963769] is unrelated to bacterial membrane preparations, and the E. coli outer membrane biogenesis paper [6836086] mentions OmpA-related OM assembly machinery but reports no 2D BN-PAGE data, no cytoplasmic (inner) membrane purity measurements, and no overexpression experiments. No evidence therefore bears on whether stronger OmpA spots in 2D BN-PAGE indicate reduced purity of cytoplasmic membranes from overexpressors.

### itrg_refresh

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=7
- 回答(insufficient): None of the three provided excerpts addresses OmpA, 2D BN-PAGE, cytoplasmic membrane purity, or overexpressing strains; they concern desmosomal/hemidesmosomal protein localization in oral carcinoma, outer membrane biogenesis in E. coli, and cytoplasmic Ca2+ oscillations. The single excerpt on E. coli outer membrane assembly [6836086] does not report OmpA band intensities or BN-PAGE gels, so it neither supports nor refutes the claim. The stated causal link between membrane purity and stronger OmpA spots is therefore unverifiable from the supplied evidence.

### itrg_refine

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=8
- 回答(insufficient): None of the three retrieved excerpts addresses the claim: they describe desmosomal/hemidesmosomal protein expression in oral squamous cell carcinoma, a multiprotein complex for outer membrane biogenesis in E. coli, and cytoplasmic Ca2+ oscillations, respectively. No excerpt reports 2D BN-PAGE gels, OmpA spot intensity, or membrane purity in overexpressors, so the claim cannot be verified. The only topically adjacent source (6836086, E. coli outer membrane biogenesis) contains no BN-PAGE, OmpA quantitation, or purity data.

### search_o1

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.500 judge=8
- 回答(insufficient): None of the three retrieved excerpts address 2D BN-PAGE gels, OmpA spot intensity, cytoplasmic membrane preparations, or overexpressing strains; they concern small-molecule reprogramming, Myc-driven translation, and outer membrane protein assembly genetics. No evidence excerpt mentions or evaluates membrane purity or OmpA detection, so the claim cannot be confirmed or refuted from the supplied material.

### deepread

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=6
- 回答(insufficient): No evidence excerpts were retrieved from the corpus, so the claim that reduced cytoplasmic membrane purity in overexpressors is indicated by stronger OmpA spots on 2D BN-PAGE gels cannot be assessed. The assertion links membrane purity to OmpA spot intensity, but no supporting or contradicting data (spot intensities, purity measurements, overexpressor vs. control comparisons) is available. Verification requires the relevant gel/membrane-purity results from the corpus.

## sf-024 — Reduction of purity of cytoplasmic membranes isolated from overexpressors is indicated by stronger spots for OmpF in 2D BN-PAGE gels.

金标: 6836086

中间 Agent 排名: deepread(10.0) > dense_rag(9.0) > itrg_refine(9.0) > itrg_refresh(9.0) > qdcvr(9.0) > raptor(9.0) > search_o1(9.0) > dense_rag_rerank(8.5)

### qdcvr

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=3
- 回答(insufficient): The retrieved excerpts concern WFS1/adenylyl cyclase 8 signaling at the plasma membrane and spatial Ca2+ oscillations driving gene expression, respectively. Neither excerpt mentions OmpF, 2D BN-PAGE, cytoplasmic membrane isolation, or overexpressor purity, so the claim cannot be evaluated from this evidence.

### dense_rag

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=8
- 回答(insufficient): None of the three provided excerpts addresses 2D BN-PAGE, OmpF spot intensity, or cytoplasmic membrane purity in overexpressors; the closest item concerns outer membrane biogenesis in E. coli but reports only a multiprotein assembly complex and genetic interactions with imp, with no gel-based purity assessment. The claim therefore cannot be evaluated from the supplied evidence.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(insufficient): None of the three retrieved excerpts address the claim: they cover outer membrane biogenesis in E. coli, desmosomal/hemidesmosomal protein expression in oral cancer, and WFS1/AC8 interaction in β-cells. No excerpt mentions 2D BN-PAGE gels, OmpF spots, cytoplasmic membrane isolation, or overexpressor strains, so the claim cannot be evaluated from this evidence. Assessment requires source material reporting 2D BN-PAGE analysis of membrane fractions from overexpressors.

### raptor

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.500 judge=3
- 回答(insufficient): The retrieved evidence is entirely unrelated to the claim: one excerpt concerns desmosomal/hemidesmosomal protein expression in oral squamous cell carcinoma, and the other concerns Igf2/H19 imprinting in mouse ES cells. Neither mentions OmpF, 2D BN-PAGE, cytoplasmic membrane isolation, overexpressors, or membrane purity, so the claim cannot be assessed from this corpus.

### itrg_refresh

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=7
- 回答(insufficient): The retrieved excerpts do not address the claim. Source 6836086 concerns the identification of a multiprotein (YfgL-containing) complex for outer membrane biogenesis in E. coli but never mentions OmpF, 2D BN-PAGE, membrane purity, or overexpressors, while source 22963769 concerns desmosomal/hemidesmosomal protein localization in oral squamous cell carcinoma and is unrelated. No evidence on OmpF spot intensity in BN-PAGE gels or on purity of cytoplasmic membranes from overexpressors is present, so the claim cannot be evaluated.

### itrg_refine

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=8
- 回答(insufficient): None of the three provided excerpts addresses 2D BN-PAGE, OmpF spot intensity, or cytoplasmic membrane purity in overexpressors; the closest item concerns outer membrane biogenesis in E. coli but reports only a multiprotein assembly complex and genetic interactions with imp, with no gel-based purity assessment. The claim therefore cannot be evaluated from the supplied evidence.

### search_o1

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=7
- 回答(insufficient): The two retrieved excerpts are unrelated to the claim: [8185080] concerns small-molecule enhancement of induced pluripotent stem cell reprogramming, and [94109411] concerns Au/Zn/Au ohmic contacts for p-type InP. Neither mentions OmpF, cytoplasmic membranes, overexpressors, or 2D BN-PAGE, so no evidence bears on whether stronger OmpF spots indicate reduced membrane purity.

### deepread

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=8
- 回答(insufficient): No evidence excerpts were retrieved from the corpus, and a direct search of the available knowledge bases for OmpF, 2D BN-PAGE, overexpressors, and cytoplasmic-membrane purity returned no relevant passages (the only outer-membrane-related document, the E. coli OM biogenesis paper [6836086], is an abstract that never mentions OmpF, BN-PAGE, or membrane purity). The claim therefore cannot be confirmed or refuted from the provided evidence.

## sf-025 — Removal of H3K9me3 by ectopic expression of other H3K9 demethylases decreases reprogramming efficiency in SCNT experiments.

金标: 4547102

中间 Agent 排名: raptor(10.0) > itrg_refine(10.0) > dense_rag_rerank(9.0) > itrg_refresh(9.0) > search_o1(9.0) > qdcvr(9.0) > deepread(9.0) > dense_rag(8.0)

### qdcvr

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(refuted): The corpus evidence directly contradicts the claim: overexpression (ectopic expression) of the H3K9 demethylase KDM4E in bovine SCNT embryos reduced the H3K9me3/2 barrier and increased cloning efficiency, blastocyst formation, and transcriptome restoration. Thus removal of H3K9me3 by an ectopic H3K9 demethylase improved, rather than decreased, reprogramming efficiency. The only other excerpt concerns HDAC inhibition via valproic acid and does not address H3K9 demethylases.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The evidence reports the opposite direction: ectopic overexpression of the H3K9 demethylase KDM4E in bovine SCNT embryos increases cloning efficiency and improves blastocyst formation. KDM4D and KDM4E are identified as the H3K9me3/2 demethylases whose deficiency underlies the persistent H3K9me3 barrier, so their expression (i.e., H3K9me3 removal) rescues rather than reduces reprogramming. The claim that such expression decreases SCNT reprogramming efficiency is therefore contradicted by the retrieved abstract.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(refuted): The claim is contradicted by the evidence: ectopic overexpression of the H3K9 demethylase KDM4E (which removes H3K9me3/2) restored the global transcriptome, improved blastocyst formation, and increased cloning efficiency of bovine SCNT embryos. Thus removal of H3K9me3 via demethylase expression is associated with increased, not decreased, reprogramming efficiency; the evidence also frames deficient KDM4D/KDM4E expression and persistent H3K9me3 barriers—not their removal—as the defect limiting SCNT reprogramming.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(refuted): The claim contradicts the evidence: bovine eight-cell SCNT embryos show global hypermethylation of H3K9me3/2 because H3K9 demethylases KDM4D and KDM4E are deficiently expressed at EGA, so the H3K9me3 barrier is abnormally high rather than removed. Ectopic (over)expression of KDM4E, which mediates active H3K9me3/2 demethylation, restores the global transcriptome, improves blastocyst formation, and increases SCNT cloning efficiency. Thus demethylase-driven H3K9me3 removal enhances, not decreases, reprogramming efficiency.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(refuted): The claim is contradicted by the evidence: ectopic overexpression of the H3K9 demethylase KDM4E (which removes H3K9me3/2) restored the global transcriptome, improved blastocyst formation, and increased cloning efficiency of bovine SCNT embryos. Thus removal of H3K9me3 via demethylase expression is associated with increased, not decreased, reprogramming efficiency; the evidence also frames deficient KDM4D/KDM4E expression and persistent H3K9me3 barriers—not their removal—as the defect limiting SCNT reprogramming.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(refuted): The corpus directly contradicts the claim: in bovine SCNT embryos, global H3K9me3/2 hypermethylation is a barrier to reprogramming, and ectopic overexpression of the H3K9 demethylase KDM4E removes this mark and increases cloning efficiency, improves blastocyst formation, and restores the transcriptome. Thus removal of H3K9me3 by a demethylase increases, not decreases, SCNT reprogramming efficiency. The remaining excerpts concern H3K4 methylation and HDAC inhibition in iPSC reprogramming and do not support the claim either.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The evidence shows the opposite: H3K9me3/2 hypermethylation is a barrier in bovine SCNT embryos at EGA, and overexpression of the H3K9 demethylase KDM4E (which removes H3K9me3/2) restores the global transcriptome, improves blastocyst formation, and increases cloning efficiency. Removal of H3K9me3 via KDM4E/KDM4D ectopic expression therefore enhances rather than decreases SCNT reprogramming efficiency. The claim that such removal decreases reprogramming efficiency is contradicted for the demethylases examined.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): Evidence [4547102] directly contradicts the claim: in bovine SCNT embryos, ectopic overexpression of the H3K9 demethylase KDM4E (which removes H3K9me3/2) restored the global transcriptome, improved blastocyst formation, and increased cloning efficiency. The claim that H3K9me3 removal by ectopic H3K9 demethylases decreases reprogramming efficiency is therefore not supported but refuted. Evidence [8185080] concerns HDAC inhibitors (VPA) in mouse/human iPSC reprogramming, not H3K9 demethylases or SCNT, and is irrelevant to the claim.

## sf-026 — Removal of H3K9me3 by ectopic expression of other H3K9 demethylases improves reprogramming efficiency in SCNT experiments.

金标: 4547102

中间 Agent 排名: qdcvr(10.0) > itrg_refine(10.0) > search_o1(10.0) > dense_rag_rerank(9.0) > itrg_refresh(9.0) > raptor(9.0) > deepread(9.0) > dense_rag(9.0)

### qdcvr

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(supported): Evidence [4547102] shows that the H3K9 demethylases KDM4D and KDM4E are deficiently expressed in bovine SCNT embryos and that ectopic overexpression of KDM4E restores the global transcriptome, improves blastocyst formation, and increases SCNT cloning efficiency, indicating that removing the persistent H3K9me3/2 barrier improves reprogramming. Evidence [8185080] on VPA/HDAC inhibitors is about iPSC induction, not H3K9 demethylases or SCNT, so it does not bear on the claim.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The retrieved evidence shows that H3K9me3/2 are globally hypermethylated in bovine SCNT embryos at embryonic genome activation and that KDM4D/KDM4E are H3K9 demethylases deficiently expressed in cloned embryos. Ectopic overexpression of the H3K9 demethylase KDM4E restored the global transcriptome, improved blastocyst formation, and increased cloning efficiency of SCNT embryos, consistent with the claim that removing H3K9me3 via H3K9 demethylase expression improves SCNT reprogramming. Caveat: the excerpt documents KDM4E (and involvement of KDM4D) specifically, so the plural/generic phrasing 'other H3K9 demethylases' is only directly evidenced for KDM4E.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows that SCNT embryos exhibit persistent H3K9me3/2 hypermethylation due to deficient expression of the H3K9 demethylases KDM4D and KDM4E at embryonic genome activation, and that overexpression (ectopic expression) of KDM4E removes this H3K9me3 barrier, restores the global transcriptome, improves blastocyst formation, and increases SCNT cloning efficiency. Thus removal of H3K9me3 via an ectopically expressed H3K9 demethylase does improve reprogramming efficiency in SCNT.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence directly shows that H3K9 demethylase KDM4E is deficiently expressed in bovine SCNT embryos at embryonic genome activation, and that its overexpression (which removes the H3K9me3/2 barrier) restores the global transcriptome, improves blastocyst formation, and increases SCNT cloning efficiency; KDM4D and KDM4E are both implicated in active H3K9me3/2 demethylation. The claim is therefore supported for the H3K9 demethylases KDM4E/KDM4D in SCNT, though the excerpt demonstrates overexpression of KDM4E specifically rather than multiple distinct ectopically expressed demethylases, and the second source (VPA/small molecules in iPSCs) is not relevant to SCNT or H3K9 demethylases.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows that SCNT embryos exhibit persistent H3K9me3/2 hypermethylation due to deficient expression of the H3K9 demethylases KDM4D and KDM4E at embryonic genome activation, and that overexpression (ectopic expression) of KDM4E removes this H3K9me3 barrier, restores the global transcriptome, improves blastocyst formation, and increases SCNT cloning efficiency. Thus removal of H3K9me3 via an ectopically expressed H3K9 demethylase does improve reprogramming efficiency in SCNT.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): Source [4547102] shows that the H3K9 demethylases KDM4D and KDM4E mediate active H3K9me3/2 demethylation and are deficiently expressed in bovine SCNT embryos at embryonic genome activation. Ectopic overexpression of KDM4E removes the persistent H3K9me3/2 barrier, restores the global transcriptome, improves blastocyst formation, and increases cloning efficiency of SCNT embryos. The other two sources concern HDAC inhibition [8185080] and H3K4 methyltransferase (MLL1) inhibition [6441369] and do not bear on H3K9me3 removal in SCNT.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(supported): Source 4547102 shows that the H3K9 demethylases KDM4D and KDM4E mediate active H3K9me3/2 demethylation in IVF embryos but are deficiently expressed in SCNT embryos at EGA, and that ectopic overexpression of KDM4E restores the global transcriptome, improves blastocyst formation, and increases SCNT cloning efficiency. This directly supports the claim that H3K9me3 removal via ectopic H3K9 demethylase expression improves reprogramming efficiency in SCNT. Source 11532659 concerns H3(T118) phosphorylation and nucleosome remodeling and provides no evidence on H3K9me3 demethylation or SCNT.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(supported): The evidence shows that the H3K9 demethylases KDM4D and KDM4E mediate active H3K9me3/2 demethylation and are deficiently expressed in bovine SCNT embryos at embryonic genome activation. Overexpression of KDM4E removes the H3K9me3/2 barrier, restores the global transcriptome, improves blastocyst formation, and increases SCNT cloning efficiency, supporting the claim that ectopic H3K9 demethylase expression improves reprogramming efficiency.

## sf-027 — Removal of H3K9me3 improves reprogramming efficiency in human somatic cell nuclear transfer experiments.

金标: 4547102

中间 Agent 排名: dense_rag_rerank(10.0) > search_o1(10.0) > dense_rag(9.5) > itrg_refine(9.5) > itrg_refresh(9.5) > qdcvr(9.5) > deepread(9.5) > raptor(7.0)

### qdcvr

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=8
- 回答(insufficient): The corpus shows that H3K9me3/2 hypermethylation acts as a barrier to SCNT-mediated reprogramming and that overexpressing the H3K9 demethylase KDM4E improves blastocyst formation and cloning efficiency, but this was demonstrated only in bovine embryos, not human cells. The other excerpt concerns small-molecule enhancement of factor-based iPSC induction, not H3K9me3 removal or SCNT. No evidence addresses human SCNT, so the claim is not established by the provided excerpts.

### dense_rag

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.500 judge=9
- 回答(insufficient): The corpus supports the mechanistic direction only in a non-human system: in bovine SCNT embryos, overexpression of the H3K9 demethylase KDM4E reduces the persistent H3K9me3/2 barrier and increases cloning/blastocyst efficiency [4547102]. No evidence excerpt reports H3K9me3 removal in human SCNT; the human data present concerns HDAC inhibition (VPA) improving iPSC induction, not H3K9me3 demethylation or SCNT [8185080]. The human-specific claim is therefore not established by the provided evidence, though the bovine result is consistent with it.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(insufficient): The evidence shows that H3K9me3/2 barriers impair reprogramming and that overexpression of the H3K9 demethylase KDM4E (reducing H3K9me3/2) restores the transcriptome and increases cloning efficiency in SCNT embryos, supporting the general mechanism. However, the cited study is exclusively in bovine embryos; no human SCNT data is provided, so the claim as stated for human somatic cell nuclear transfer is not directly supported.

### raptor

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.356 judge=3
- 回答(insufficient): The evidence establishes that H3K9 methylation marks heterochromatin and mediates gene silencing via HP1 proteins, and separately that DNA methyltransferase/HDAC inhibitors (e.g. VPA) raise reprogramming efficiency by over 100-fold, but no excerpt tests removal of H3K9me3, and none concerns human somatic cell nuclear transfer. The cited material does not measure reprogramming efficiency in SCNT at all, so the claim cannot be evaluated from it. Direct evidence linking H3K9me3 demethylation to improved human SCNT reprogramming is absent.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(insufficient): The corpus supports that H3K9me3 demethylation (via KDM4E/KDM4D overexpression) relieves the H3K9me3 barrier and improves SCNT cloning efficiency, but this evidence is from bovine embryos, not human. The only human-related excerpt concerns HDAC/DNMT inhibitors (VPA) improving iPSC induction from transcription-factor reprogramming, not H3K9me3 removal in human SCNT. No human somatic cell nuclear transfer experiment addressing H3K9me3 removal is provided, so the human-specific claim is unverified.

### itrg_refine

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.500 judge=9
- 回答(insufficient): The corpus supports the mechanistic direction only in a non-human system: in bovine SCNT embryos, overexpression of the H3K9 demethylase KDM4E reduces the persistent H3K9me3/2 barrier and increases cloning/blastocyst efficiency [4547102]. No evidence excerpt reports H3K9me3 removal in human SCNT; the human data present concerns HDAC inhibition (VPA) improving iPSC induction, not H3K9me3 demethylation or SCNT [8185080]. The human-specific claim is therefore not established by the provided evidence, though the bovine result is consistent with it.

### search_o1

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.500 judge=8
- 回答(insufficient): The only relevant evidence (KDM4E/KDM4D) shows that removing the H3K9me3/2 barrier via H3K9 demethylase overexpression improves blastocyst formation and cloning efficiency in bovine SCNT embryos, not human. No retrieved excerpt reports H3K9me3 removal in human SCNT experiments; the human reprogramming studies cited concern HDAC inhibition (VPA) and lineage specifiers, not H3K9me3. The claim's human-specific aspect is therefore unsupported by the corpus.

### deepread

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.500 judge=10
- 回答(insufficient): The corpus contains no human somatic cell nuclear transfer data addressing H3K9me3 removal; the only directly relevant finding [4547102] shows that overexpression of the H3K9 demethylase KDM4E improves blastocyst formation and cloning efficiency in bovine SCNT embryos, establishing the H3K9me3 barrier mechanism but only in cattle. The remaining excerpts concern transcription-factor-based iPSC reprogramming enhanced by HDAC/DNMT inhibitors [8185080] or lineage-specifier replacement of OCT4/SOX2 [16287725], neither of which involves SCNT or H3K9me3 manipulation. The claim's human-specific extrapolation is therefore not established by this evidence.

## sf-028 — Replacement of OCT4 and SOX2 genes with GATA3 has the ability to reprogram human cells.

金标: 16287725

中间 Agent 排名: itrg_refine(10.0) > dense_rag(10.0) > deepread(10.0) > search_o1(9.5) > raptor(9.5) > dense_rag_rerank(9.0) > qdcvr(9.0) > itrg_refresh(8.5)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=5
- 回答(insufficient): The corpus evidence confirms that lineage specifiers can replace OCT4 and SOX2 simultaneously to reprogram human fibroblasts [16287725], and that OCT4 had not previously been replaced in human cells. However, no excerpt names GATA3 specifically as the replacing factor, so the claim's identification of GATA3 with this capability is not directly corroborated. The second excerpt concerns small-molecule enhancement of standard factor reprogramming and is irrelevant to the claim.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): The evidence shows that OCT4 and SOX2 can be replaced simultaneously by unidentified lineage specifiers to reprogram human fibroblasts, but the specific factor GATA3 is never named in any excerpt. Thus the claim that GATA3 specifically accomplishes this replacement is not confirmed by the provided evidence.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=5
- 回答(insufficient): The corpus supports that OCT4 and SOX2 can be replaced simultaneously by alternative lineage specifiers during reprogramming of human fibroblasts, but no excerpt identifies GATA3 as the replacing factor. Because the claim names GATA3 specifically, and the evidence only refers to unnamed lineage specifiers, the specific claim is not established. The small-molecule paper is irrelevant to the identity of the replacing factor.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(insufficient): The excerpts (16287725) establish that OCT4 and SOX2 can be replaced simultaneously in human fibroblasts by alternative lineage-specifier factors, but they never name GATA3 as the replacing factor. The GATA3-specific claim is therefore not corroborated by the supplied evidence, which speaks only of unidentified 'lineage specifiers' generally.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=6
- 回答(insufficient): The retrieved evidence (16287725) states only that unidentified 'lineage specifiers' can replace OCT4 and SOX2 simultaneously in human fibroblast reprogramming; it never names GATA3. No excerpt links GATA3 to OCT4/SOX2 replacement, so the specific claim about GATA3 is not verifiable from the provided corpus. The other excerpts concern chemical enhancement of reprogramming and glioblastoma tumor suppressors, and are irrelevant.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=4
- 回答(insufficient): The evidence [16287725] shows that OCT4 and SOX2 can be replaced simultaneously by alternative lineage specifiers during reprogramming of human fibroblasts, but it never identifies GATA3 as one of those factors. Since no excerpt names GATA3 specifically, the claim that GATA3 itself performs this replacement is not verifiable from the provided evidence.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): The evidence shows that OCT4 and SOX2 can be replaced simultaneously by lineage specifiers to reprogram human fibroblasts, supporting the general feasibility of such replacement. However, the excerpt never names GATA3 among the identified lineage specifiers, so the specific claim that GATA3 replaces OCT4 and SOX2 is not directly established by this evidence.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(insufficient): The evidence supports that OCT4 and SOX2 can be replaced simultaneously by alternative lineage specifiers during reprogramming of human fibroblasts, but it does not name GATA3 or any specific factor used. The claim's specific attribution to GATA3 therefore cannot be confirmed from this excerpt alone.

## sf-029 — Replacement of OCT4 and SOX2 genes with GATA3 is not capable of reprogramming human cells.

金标: 16287725

中间 Agent 排名: deepread(10.0) > dense_rag(9.0) > raptor(9.0) > search_o1(8.0) > dense_rag_rerank(8.0) > itrg_refine(6.0) > itrg_refresh(6.0) > qdcvr(5.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=5
- 回答(insufficient): The retrieved evidence [16287725] reports that OCT4 and SOX2 can be replaced simultaneously by unidentified 'lineage specifiers' in human fibroblast reprogramming, which runs counter to the claim's general direction, but the excerpt never names GATA3 and provides no data on GATA3-containing factor combinations. Source [8185080] concerns small-molecule enhancement of standard factor reprogramming and says nothing about GATA3 or factor replacement. Therefore the specific claim about GATA3 cannot be confirmed or refuted from the given excerpts.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(refuted): The retrieved evidence [16287725] reports the opposite: it explicitly identifies lineage specifiers able to replace OCT4 and SOX2 simultaneously in the reprogramming of human fibroblasts, stating that this replacement is possible in human cells. Therefore the claim that such replacement cannot reprogram human cells contradicts the source. Caveat: the excerpt does not name GATA3 explicitly, only "alternative lineage specifiers" of this class.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=8
- 回答(refuted): The claim is contradicted by source 16287725, which reports that OCT4 and SOX2 can be replaced simultaneously by alternative lineage specifiers (a class of factors that includes GATA3) to reprogram human fibroblasts to pluripotency. Rather than being incapable, OCT4/SOX2 replacement in human cells was demonstrated to be achievable. The remaining evidence on small-molecule enhancement of reprogramming is unrelated to the claim.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(refuted): The retrieved evidence directly contradicts the claim: it reports that OCT4 and SOX2 can be replaced simultaneously by alternative lineage specifiers in the reprogramming of human fibroblasts, which was previously not achieved for OCT4. The claim that such a substitution is incapable of reprogramming human cells is therefore refuted. Caveat: the excerpts do not explicitly name GATA3 as the lineage specifier used, only reference lineage specifiers generically.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=6
- 回答(insufficient): The available evidence establishes that lineage specifiers can replace OCT4 and SOX2 simultaneously in reprogramming human fibroblasts, but it does not identify GATA3 as the factor used, nor does it test GATA3 specifically. Therefore the claim about GATA3 in particular is neither confirmed nor refuted by the excerpts; if GATA3 is one of the lineage specifiers employed, the evidence would tend to refute the claim, but this is not stated in the provided text. The remaining excerpts (small-molecule enhancement, glioblastoma INK4 circuitry) are off-topic.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=6
- 回答(insufficient): The evidence [16287725] shows that OCT4 and SOX2 can be replaced simultaneously by unspecified lineage specifiers to reprogram human fibroblasts, which is consistent with replacement being possible but never names GATA3 as one of the factors. The claim specifically asserts GATA3 is not capable, which cannot be confirmed or refuted without the excerpt naming GATA3 or reporting its individual outcome. Other excerpts are unrelated to reprogramming factor replacement.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(refuted): The claim is refuted: source [16287725] reports that OCT4 and SOX2 can be replaced simultaneously by alternative lineage specifiers during reprogramming of human fibroblasts, demonstrating that such replacement is achievable in human cells. It also states that, unlike in mouse, OCT4 had not previously been replaced successfully in human cells, but that this strategy accomplishes that replacement. Source [2086909] (Tet1 in mouse ESCs) is irrelevant to the claim.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(refuted): The evidence reports that OCT4 and SOX2 can be replaced simultaneously by alternative lineage specifiers in the reprogramming of human fibroblasts, directly contradicting the claim that such replacement is incapable of reprogramming human cells. The excerpt does not name GATA3 explicitly, but it establishes that lineage-specifier replacement of OCT4/SOX2 in human cells is achievable, which refutes the claim's assertion of impossibility.

## sf-030 — Allogeneic mechanical circulatory support is not as effective as autologous mechanical circulatory support for treating acute myocardial infarction.

金标: 40164383

中间 Agent 排名: qdcvr(10.0) > itrg_refine(9.0) > raptor(9.0) > search_o1(8.0) > deepread(6.0) > dense_rag(6.0) > dense_rag_rerank(6.0) > itrg_refresh(6.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=5
- 回答(insufficient): The retrieved evidence does not test mechanical circulatory support at all; the POSEIDON trial [40164383] compared transendocardial injections of allogeneic vs autologous bone marrow-derived mesenchymal stem cells in ischemic cardiomyopathy, not devices for acute myocardial infarction. Its finding that autologous but not allogeneic MSC therapy improved 6-minute walk test and MLHFQ score is cell-therapy-specific and cannot establish anything about mechanical circulatory support efficacy. The second excerpt [11899391] concerns IL2RA/Treg biology in type 1 diabetes and is irrelevant.

### dense_rag

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=6
- 回答(insufficient): The retrieved evidence (POSEIDON trial) compares allogeneic vs autologous bone marrow-derived MSCs in patients with ischemic cardiomyopathy, not acute myocardial infarction, so it does not address the claim's population. The excerpt reports only the study design and outcome measures, providing no efficacy results; thus superiority or non-inferiority of either cell source cannot be determined.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=6
- 回答(insufficient): The retrieved evidence (POSEIDON trial) compares allogeneic vs autologous bone marrow-derived MSCs in patients with ischemic cardiomyopathy, not acute myocardial infarction, so it does not address the claim's population. The excerpt reports only the study design and outcome measures, providing no efficacy results; thus superiority or non-inferiority of either cell source cannot be determined.

### raptor

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=10
- 回答(insufficient): The only evidence provided concerns transendocardial injection of allogeneic vs autologous bone marrow–derived mesenchymal stem cells in patients with ischemic cardiomyopathy (POSEIDON trial), not mechanical circulatory support, and its population is ischemic cardiomyopathy rather than acute myocardial infarction. The excerpt reports a phase 1/2 safety comparison (treatment-emergent SAE rates and planned efficacy assessments) and states only that allogeneic and autologous MSC efficacy "have not been compared"; it provides no comparative effectiveness data on any mechanical circulatory support device. Thus the claim is neither supported nor refuted by this evidence.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=6
- 回答(insufficient): The retrieved evidence (POSEIDON trial) compares allogeneic vs autologous bone marrow-derived MSCs in patients with ischemic cardiomyopathy, not acute myocardial infarction, so it does not address the claim's population. The excerpt reports only the study design and outcome measures, providing no efficacy results; thus superiority or non-inferiority of either cell source cannot be determined.

### itrg_refine

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): The only potentially relevant excerpt (POSEIDON) compares allogeneic vs autologous mesenchymal stem cell therapy in ischemic cardiomyopathy, not mechanical circulatory support, and no excerpt addresses acute myocardial infarction or reports efficacy outcomes for such a comparison. The second excerpt concerns metformin/AMPK and is unrelated. The retrieved evidence therefore does not test the claim's intervention (mechanical circulatory support) or population (acute myocardial infarction), so no assessment can be made.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): The only retrieved evidence [40164383] concerns allogeneic vs autologous bone marrow–derived mesenchymal stem cell therapy delivered by transendocardial injection in ischemic cardiomyopathy, not mechanical circulatory support, and it reports no efficacy comparison favoring one cell source over the other. No evidence addresses allogeneic vs autologous mechanical circulatory support, nor the acute myocardial infarction population specified in the claim, so the claim cannot be evaluated from the given excerpts.

### deepread

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=6
- 回答(insufficient): The cited evidence (POSEIDON) compares allogeneic vs autologous mesenchymal stem cell injections in ischemic cardiomyopathy, not mechanical circulatory support in acute myocardial infarction, so it does not test the claim's intervention or condition. Only safety data (30-day treatment-emergent SAE rate 6.7% in each group) are shown; the efficacy comparison is truncated and never reported. No evidence in the excerpt addresses the relative effectiveness of allogeneic versus autologous mechanical circulatory support for acute MI.
